Page last updated: 2024-12-09

cinnamaldehyde

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-phenylprop-2-enal : A member of the class of cinnamaldehydes that is prop-2-enal in which a hydrogen at position 3 has been replaced by a phenyl group. The configuration of the double bond is not specified; the name "cinnamaldehyde" is widely used to refer to the E (trans) isomer. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

(E)-cinnamaldehyde : The E (trans) stereoisomer of cinnamaldehyde, the parent of the class of cinnamaldehydes. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID637511
CHEMBL ID293492
CHEBI ID16731
CHEBI ID142921
SCHEMBL ID3441
MeSH IDM0060175

Synonyms (163)

Synonym
gtpl2423
trans-cinnamic aldehyde
(3e)-3-phenylprop-2-enal
(e)-cinnamaldehyde
(e)-3-phenyl-2-propenal
CHEBI:16731 ,
(e)-cinnamic aldehyde
(e)-3-phenylpropenal
nsc40346
nsc-40346
trans-cinnamaldehyde
(e)-3-phenylprop-2-enal
14371-10-9
cnma
caswell no. 221a
3-phenyl-2-propen-1-al
hefty dog and cat repellent
cinnamic aldehyde (natural)
aldehyd skoricovy [czech]
fema no. 2286
ccris 6222
einecs 203-213-9
hsdb 209
abion ca
epa pesticide chemical code 040506
fema number 2286
beta-phenylcrolein
cinnemaldehyde
ai3-00473
brn 0605737
cinnamyl aldehyde
3-fenylpropenal [czech]
nsc-16935
3-phenyl-2-propenaldehyde
cinnamylaldehyde
nsc16935
nci-c56111
3-phenylacrolein
benzylideneacetaldehyde
wln: vh1u1r
acrolein, 3-phenyl-
3-phenylpropenal
3-phenyl-2-propenal
cinnamaldehyde, (e)-
inchi=1/c9h8o/c10-8-4-7-9-5-2-1-3-6-9/h1-8h/b7-4
(2e)-3-phenylacrylaldehyde
2-propenal, 3-phenyl-, (2e)-
cinnamaldehyde (trans)
NCGC00091512-01
NCGC00091512-02
trans-cinnamylaldehyde
trans-3-phenyl-2-propenal
brn 1071571
ai3-33275
2-propenal, 3-phenyl-, (e)-
ccris 3189
(e)-cinnamaldehyde (incorrect)
cinnamic aldehyde
C00903
cassia aldehyde
2-propenal, 3-phenyl-
phenylacrolein
cinnamal
zimtaldehyde
trans-cinnamaldehyde (incorrect)
CINNAMALDEHYDE ,
3-phenylacrylaldehyde
104-55-2
cinnamaldehyde, natural, >=95%, fg
trans-cinnamaldehyde, >=98%, fcc, fg
trans-cinnamaldehyde, 99%
NCGC00091512-04
trans-cinnamaldehyde, >=99%
cinnamaldehyde (trans), neat
STK397371
(2e)-3-phenylprop-2-enal
MLS002454394
smr000112334
B99DD6C7-1C6D-4FE3-A172-54BFDB987683
cinnamaldehyde, trans-
trans-3-phenylacrylaldehyde
trans-3-phenylacrolein
xc-800
.beta.-phenylacrolein
CHEMBL293492 ,
(e)-3-phenyl-2-propenal(e)-cinnamaldehyde
BMSE010257
bdbm50203065
3-phenylprop-2-enal
CHEBI:142921
AKOS000119171
A801001
NCGC00091512-07
NCGC00091512-06
NCGC00091512-05
cinnamaldehyde [nf]
3-fenylpropenal
2-07-00-00273 (beilstein handbook reference)
ec 203-213-9
unii-sr60a3xg0f
sr60a3xg0f ,
4-07-00-00984 (beilstein handbook reference)
dtxsid6024834 ,
tox21_303271
NCGC00257017-01
cas-14371-10-9
dtxcid504834
tox21_201804
NCGC00259353-01
NCGC00257826-01
dtxcid904835
cas-104-55-2
tox21_200272
(e)-3-phenyl-acrylaldehyde
tox21_111144
HMS2268O08
S3763
AM20060482
cinnamaldehyde [fcc]
trans-cinnamaldehyde (constituent of cinnamomum cassia bark) [dsc]
cinnamaldehyde [hsdb]
cinnamaldehyde [fhfi]
cinnamaldehyde [who-dd]
cinnamaldehyde [usp-rs]
cinnamaldehyde (constituent of cinnamomum verum bark) [dsc]
cinnamal [inci]
cinnamaldehyde [mi]
cinnamaldehyde [ii]
(e)-3-phenyl-propenal
(e)-phenylvinyl aldehyde
EPITOPE ID:150921
trans-cinnamaldehyde; trans-3-phenylacrylaldehyde
SCHEMBL3441
trans cinnamaldehyde
trans cinnamic aldehyde
transcinnamaldehyde
(e)-3-phenylacrylaldehyde
(trans)-cinnamaldehyde
e-cinnamaldehyde
W-205597
(2e)-3-phenyl-2-propenal
cinnamaldehyde, united states pharmacopeia (usp) reference standard
mfcd00007000
trans-cinnamaldehyde, analytical standard
cinnamaldehyde, vetec(tm) reagent grade, 93%
CS-0009609
DB14184
cinnamaldehyde min. 98%, for synthesis
trans-cinnamaldehyde ,(s)
|a-phenylacrolein
AS-12078
Q204036
A14480
EN300-19160
HMS3885E04
CCG-266119
cinnamaldehyde 100 microg/ml in toluene
D72477
trans-3-phenyl-propenal
HY-N0609
AS-75456
EN300-735819
Z3219847383

Research Excerpts

Overview

Cinnamaldehyde is an essential oil extracted from the leaves, bark, roots and flowers of cinnamon plants (genus Cinnamomum) It is reported to have a potential anti-fungal, anti-oxidant,anti-inflammatory and anticancer effect.

ExcerptReferenceRelevance
"Cinnamaldehyde is an essential oil extracted from the leaves, bark, roots and flowers of cinnamon plants (genus "( Encapsulation of cinnamaldehyde: an insight on delivery systems and food applications.
Harindintwali, JD; Koko, MYF; Li, Y; Muhoza, B; Qi, B; Zhang, S, 2023
)
2.69
"Cinnamaldehyde (Cin) is a natural product obtained from cinnamon and is reported to have a potential anti-fungal, anti-oxidant, anti-inflammatory and anticancer effect. "( Evaluation of prophylactic efficacy of cinnamaldehyde in murine model against Paradendryphiella arenariae mycotoxin tenuazonic acid-induced oxidative stress and organ toxicity.
Kumari, A; Singh, K, 2021
)
2.33
"Cinnamaldehyde is a natural antimicrobial food preservative. "( Antibacterial Mechanism of Cinnamaldehyde: Modulation of Biosynthesis of Phosphatidylethanolamine and Phosphatidylglycerol in
Huang, Z; Li, E; Li, Q; Liao, S; Pang, D; Wang, E; Wang, W; Zou, Y, 2021
)
2.36
"Cinnamaldehyde is an important component of cinnamon and has an effect on blood glucose."( Effects of cinnamaldehyde on glucose-6-phosphate dehydrogenase activity, some biochemical and hematological parameters in diabetic rats.
Çelik, R; Comba, B; Mert, H; Mert, N, 2022
)
1.83
"Cinnamaldehyde is a major component of cinnamon bark oil."( Evaluation of cinnamaldehyde mucoadhesive patches on minor recurrent aphthous stomatitis: a randomized, double-blind, placebo-controlled clinical trial.
Malekzadeh Shafaroudi, A; Molania, T; Moosazadeh, M; Rostamkalaei, SS; Saeedi, M; Salehabadi, N; Salehi, M; Valipour, F, 2022
)
1.8
"Cinnamaldehyde (CNM) is a cyclic terpene alcohol found as the major compound of essential oils from some plants of the genus Cinnamomum (Lauraceae). "( Cinnamaldehyde for the Treatment of Microbial Infections: Evidence Obtained from Experimental Models.
da Silva, LCN; de Carvalho Galvão, LC; de Holanda, RA; de Oliveira, PV; de Santana do Nascimento, M; de Sousa, TJD; Dos Reis Ferreira, L; Dos Santos, JRA; Silva E Silva Figueiredo, CS; Zagmignan, A, 2023
)
3.8
"Cinnamaldehyde (CA) is a bioactive phytochemical isolated from the stem bark of Chinese herbal medicine Cinnamon and has been suggested to possess curative roles against the development of CVDs."( The Therapeutic Roles of Cinnamaldehyde against Cardiovascular Diseases.
Liu, G; Lu, L; Mi, B; Wang, G; Xiong, Y; Zhou, J, 2022
)
1.75
"Cinnamaldehyde is a natural product with anti-inflammatory and immune-modulatory properties, known to regulate host responses to bacterial stimuli. "( Cinnamaldehyde modulates host immunoinflammatory responses in rat ligature-induced periodontitis and peripheral blood mononuclear cell models.
Aguiar-da-Silva, LD; Branco-de-Almeida, LS; Cardoso, CRB; de Oliveira, ICV; Duarte-Silva, M; Fernandes, ES; Galvão-Moreira, LV; Lima-Neto, LG; Pereira, CAA; Pereira, DMS; Pinheiro, AJMCR; Vilela, JL, 2023
)
3.8
"Cinnamaldehyde (CIN) is an active ingredient of Cinnamomum cassia with immunomodulatory and anti-inflammatory properties."( Cinnamaldehyde Ameliorates Dextran Sulfate Sodium-Induced Colitis in Mice by Modulating TLR4/NF-κB Signaling Pathway and NLRP3 Inflammasome Activation.
Chen, F; Han, Z; Ma, K; Peng, J; Su, X; Tan, X; Wang, C; Wang, T; Wang, Y; Wen, Y, 2023
)
3.07
"Cinnamaldehyde (CA) is an active ingredient of Wenyang Tongluo capsule. "( Cinnamaldehyde Induces the Expression of MicroRNA-1285-5p and MicroRNA-140-5p in Chondrocytes to Ameliorate the Apoptosis and Inflammatory Response.
Li, G; Song, Y, 2023
)
3.8
"Cinnamaldehyde is an excellent natural antioxidant with high antioxidant activity, but its function in food or human digestive tract under acidic conditions remains to be studied. "( Cinnamaldehyde Alleviates the Oxidative Stress of Caenorhabditis elegans in the Presence of Lactic Acid.
Bai, J; Darwesh, OM; Eweys, AS; Xiao, M; Xiao, X; Zhao, Y, 2023
)
3.8
"Cinnamaldehyde (CIN) is a major constituent of the cinnamon and it possesses potent antioxidative activity; however, it is unclear whether CIN is capable of inhibiting the adverse effects of UVB."( Antioxidant cinnamaldehyde attenuates UVB-induced photoaging.
Furue, M; Tanaka, Y; Uchi, H, 2019
)
1.61
"Cinnamaldehyde is a predominant constituent and key flavour compound of cinnamon essential oil. "( Antifungal activity of cinnamaldehyde against Fusarium sambucinum involves inhibition of ergosterol biosynthesis.
Bi, Y; Prusky, D; Wang, Y; Wei, J; Xue, H; Zong, Y, 2020
)
2.31
"Cinnamaldehyde (CIN) is a promising replacement for chemical synthetic preservatives, which has exhibited effective antimicrobial activities in food applications. "( The antifungal effects of cinnamaldehyde against Aspergillus niger and its application in bread preservation.
Chen, Q; Le, T; Li, J; Sun, Q; Sun, Y; Zhang, L, 2020
)
2.3
"Cinnamaldehyde (CA) is a spice compound in cinnamon that enhances the antioxidant defense against reactive oxygen species (ROS) by activating nuclear factor erythroid-related factor 2 (Nrf2), which has been shown to have a cardioprotection effect."( Cinnamaldehyde Ameliorates Vascular Dysfunction in Diabetic Mice by Activating Nrf2.
Liu, S; Wan, J; Wang, D; Wang, P; Yang, Q; Yang, Y; Zhou, P, 2020
)
2.72
"Cinnamaldehyde (CA) is a natural compound from Cinnamomum cassia, and its anticancer, antimicrobial and anti‑inflammatory activities have been widely investigated."( Cinnamaldehyde protects against oxidative stress and inhibits the TNF‑α‑induced inflammatory response in human umbilical vein endothelial cells.
Ahn, SG; Kim, NY; Kim, SA; Trinh, NT, 2020
)
2.72
"Cinnamaldehyde (CA) is an essential component of cinnamon (Cinnamomum cassia Presland), which is often used as a flavoring condiment in beverages, pastries, perfumes, etc. "( Cinnamaldehyde suppresses NLRP3 derived IL-1β via activating succinate/HIF-1 in rheumatoid arthritis rats.
Chen, H; Fu, Y; Huang, JH; Liu, P; Pan, T; Wang, F; Wang, J; Wen, W; Xu, S, 2020
)
3.44
"Cinnamaldehyde, which is a major constituent in the essential oil of cinnamon, has been previously reported to reduce xanthine oxidase activity, in addition to its anti-inflammatory, anti-oxidant, and anti-proliferative activities."( The modulatory effects of cinnamaldehyde on uric acid level and IL-6/JAK1/STAT3 signaling as a promising therapeutic strategy against benign prostatic hyperplasia.
Abdel-Rahman, HM; Abo-Youssef, AM; Afify, H; Allam, S; Azouz, AA, 2020
)
1.58
"Cinnamaldehyde (CA) is an essential component of cinnamon that has been shown to exhibit anti-tumor effects through growth inhibition and induction of apoptosis in cancer cells. "( Cinnamaldehyde induces endogenous apoptosis of the prostate cancer-associated fibroblasts via interfering the Glutathione-associated mitochondria function.
Gu, Z; Han, L; Li, J; Lou, X; Ma, J; Mei, J; Qin, Z; Tao, N; Wang, F; Yao, X; Zeng, Y; Zhang, Z, 2020
)
3.44
"Cinnamaldehyde (CA) is a major active compound from cinnamon, is known as its anti-inflammatory and antibacterial."( Suppression of Th17 cell differentiation via sphingosine-1-phosphate receptor 2 by cinnamaldehyde can ameliorate ulcerative colitis.
Chen, L; Lu, ZJ; Qu, SL; Wang, XY; Wen, XS; Yang, YF; Zuo, JP, 2021
)
1.57
"Cinnamaldehyde (CA) is a food additive that has potential use in controlling postharvest disease of fruits and vegetables."( Effect of applying cinnamaldehyde incorporated in wax on green mould decay in citrus fruits.
Duan, X; OuYang, Q; Tao, N, 2018
)
1.53
"Cinnamaldehyde is a main ingredient of cinnamon oils from the stem bark of Cinnamomum cassia, which has been widely used in food and traditional herbal medicine in Asia. "( Protective effect of cinnamaldehyde against glutamate-induced oxidative stress and apoptosis in PC12 cells.
Liu, RH; Lv, C; Yuan, X; Zeng, HW; Zhang, WD, 2017
)
2.22
"Cinnamaldehyde (CA) is a food compound that has previously been observed to be protective against obesity and hyperglycemia in mouse models. "( Cinnamaldehyde induces fat cell-autonomous thermogenesis and metabolic reprogramming.
Emont, MP; Jiang, J; Jun, H; Kim, DI; Liao, J; Qiao, X; Wu, J, 2017
)
3.34
"Cinnamaldehyde is a major constituent of cinnamon essential oils produced by aromatic cinnamon plants. "( Chemistry, Antimicrobial Mechanisms, and Antibiotic Activities of Cinnamaldehyde against Pathogenic Bacteria in Animal Feeds and Human Foods.
Friedman, M, 2017
)
2.13
"Cinnamaldehyde is a flavor isolated from the bark of Cinnamomum cassia Presl and exerts anti-inflammation effects in various diseases. "( Cinnamaldehyde attenuates atherosclerosis via targeting the IκB/NF-κB signaling pathway in high fat diet-induced ApoE
Li, W; Liu, F; Niu, X; Zang, L; Zhao, J; Zhi, W, 2019
)
3.4
"Cinnamaldehyde is an active component of some plant essential oils, which has broad antibacterial activity. "( Modulation effect of core-wall ratio on the stability and antibacterial activity of cinnamaldehyde liposomes.
Chen, W; Cheng, F; Swing, CJ; Xia, S; Zhang, X, 2019
)
2.18
"Cinnamaldehyde is an active monomer isolated from the stem bark of Cinnamomum cassia, a traditional oriental medicinal herb, which is known to possess marked antitumor effects in vitro and in vivo. "( Cinnamaldehyde/chemotherapeutic agents interaction and drug-metabolizing genes in colorectal cancer.
Liu, SL; Qi, MH; Yu, C; Zou, X, 2014
)
3.29
"Cinnamaldehyde is a major and a bioactive compound isolated from the leaves of Cinnamomum osmophloeum kaneh. "( Cinnamaldehyde and nitric oxide attenuate advanced glycation end products-induced the Jak/STAT signaling in human renal tubular cells.
Chuang, LY; Guh, JY; Huang, JS; Hwang, JY; Lee, YH, 2015
)
3.3
"Cinnamaldehyde (CA) is a key flavor compound in cinnamon essential oil that can enhance the antioxidant defense against reactive oxygen species (ROS) by activating NF-E2-related factor 2 (Nrf2), which has been shown to have a cardiovascular protective effect, but its role in endothelial dysfunction induced by high glucose is unknown."( Cinnamaldehyde prevents endothelial dysfunction induced by high glucose by activating Nrf2.
Hao, X; Hu, Y; Li, B; Liang, D; Pu, C; Wang, F; Wang, P; Wang, Q; Zhou, P, 2015
)
2.58
"Cinnamaldehyde is a diterpene with a wide range of anti-inflammatory effects thus may be advantageous in the treatment of cerebral ischaemia."( Cinnamaldehyde inhibits inflammation and brain damage in a mouse model of permanent cerebral ischaemia.
Chen, R; Dong, L; He, T; Li, L; Li, Y; Wen, Y; Zhang, C; Zhang, X; Zhang, Y; Zhao, J; Zheng, X; Zhu, X, 2015
)
2.58
"Cinnamaldehyde (CIN) is a promising natural preservative and generally recognized as safe for commodities as well as consumers. "( Cinnamaldehyde inhibits fungal growth and aflatoxin B1 biosynthesis by modulating the oxidative stress response of Aspergillus flavus.
Liu, Y; Lu, Z; Shang, B; Sun, Q; Wang, L, 2016
)
3.32
"Cinnamaldehyde (CA) is a bioactive compound isolated from the stem bark of Cinnamomum cassia, that has been identified as an antiproliferative substance with pro-apoptotic effects on various cancer cell lines in vitro. "( Cinnamaldehyde affects the biological behavior of human colorectal cancer cells and induces apoptosis via inhibition of the PI3K/Akt signaling pathway.
Chen, Y; Li, J; Liu, S; Teng, Y; Wang, R; Wang, Z; Xi, S; Xu, S; Zhang, Y; Zou, X, 2016
)
3.32
"Cinnamaldehyde analogues are a class of chemical substances originated from derivatization of cinnamaldehyde, and are structurally characterized by the presence of cinnamoyl moiety. "( Cinnamaldehyde Analogues as Potential Therapeutic Agents.
Chen, BJ; Fu, CS; Li, GH; Lou, HX; Ren, DM; Shen, T; Wang, XN, 2017
)
3.34
"Cinnamaldehyde is a major bioactive compound isolated from the leaves of Cinnamomum osmophloeum. "( Cinnamaldehyde attenuates pressure overload-induced cardiac hypertrophy.
Bian, ZY; Hu, ZF; Liu, Y; Tang, QZ; Wu, QQ; Yang, L, 2015
)
3.3
"Cinnamaldehyde is a natural essential oil suggested to possess anti-bacterial and anti-inflammatory properties; and to activate transient receptor potential ankyrin 1 (TRPA1) channels expressed on neuronal and non-neuronal cells. "( Cinnamaldehyde modulates LPS-induced systemic inflammatory response syndrome through TRPA1-dependent and independent mechanisms.
Costa, SKP; da Costa, R; Fernandes, ES; Ferro, TAF; Grisotto, MAG; Mendes, SJF; Monteiro-Neto, V; Mouchrek, AQS; Nascimento, JLM; Pereira, DMS; Pereira, ICP; Pinheiro, AJMCR; Silva, BLR; Sousa, FIAB, 2016
)
3.32
"Cinnamaldehyde (CIN) is a natural antibacterial ingredient found in the bark and leaves of cinnamon trees."( An in vitro investigation of the inhibitory mechanism of β-galactosidase by cinnamaldehyde alone and in combination with carvacrol and thymol.
Gong, DM; Huang, YB; Wang, LH; Wang, MS; Zeng, XA, 2017
)
1.41
"Cinnamaldehyde is a major and a bioactive compound isolated from the leaves of Cinnamomum osmophloeum kaneh. "( Cinnamaldehyde impairs high glucose-induced hypertrophy in renal interstitial fibroblasts.
Chang, WT; Chao, LK; Huang, JS; Shih, YW, 2010
)
3.25
"Cinnamaldehyde (1) is a pharmacologically active ingredient isolated from cassia twig (Ramulus Cinnamomi), which is commonly used in herbal remedies to treat fever-related diseases. "( Cinnamaldehyde up-regulates the mRNA expression level of TRPV1 receptor potential ion channel protein and its function in primary rat DRG neurons in vitro.
Du, XL; Guo, JY; Guo, SY; Huo, HR; Jiang, TL; Li, LF; Lin, N; Liu, HB; Sui, F; Yang, N; Zhang, CB; Zhao, BS, 2010
)
3.25
"Cinnamaldehyde is a naturally occurring α,β-unsaturated aldehyde. "( Functional properties of bioplastics made from wheat gliadins modified with cinnamaldehyde.
Balaguer, MP; Gavara, R; Gómez-Estaca, J; Hernandez-Munoz, P, 2011
)
2.04
"Cinnamaldehyde is a well-established natural antimicrobial compound. "( The antimicrobial activities of the cinnamaldehyde adducts with amino acids.
Jiang, H; Wei, QY; Xiong, JJ; Zhang, C, 2011
)
2.09
"Cinnamaldehyde is a natural antimicrobial that has been found to be effective against many food-borne pathogens, including Escherichia coli O157:H7. "( Examination of the genome-wide transcriptional response of Escherichia coli O157:H7 to cinnamaldehyde exposure.
Hernandez-Doria, JD; Holley, RA; Visvalingam, J, 2013
)
2.06
"Cinnamaldehyde is an active compound isolated from the stem bark of Cinnamomum cassia, a traditional oriental medicinal herb, which has been shown to inhibit tumor cell proliferation. "( Cinnamaldehyde induces apoptosis by ROS-mediated mitochondrial permeability transition in human promyelocytic leukemia HL-60 cells.
Cho, KS; Choi, JW; Ha, J; Jung, HJ; Ka, H; Lee, KT; Park, HJ, 2003
)
3.2
"Cinnamaldehyde is a principle compound isolated from Guizhi-Tang, which is a famous traditional Chinese medical formula used to treat influenza, common cold and other pyretic conditions. "( Cinnamaldehyde reduces IL-1beta-induced cyclooxygenase-2 activity in rat cerebral microvascular endothelial cells.
Guo, JY; Guo, SY; Huo, HR; Jiang, TL; Li, LF; Liu, HB; Ma, YY; Zhao, BS, 2006
)
3.22
"Cinnamaldehyde is a natural product from spices that inhibits cell separation in Bacillus cereus. "( Inhibition of bacterial cell division protein FtsZ by cinnamaldehyde.
Bhunia, A; Dasgupta, D; Domadia, P; Sivaraman, J; Swarup, S, 2007
)
2.03
"Cinnamaldehyde is a principle compound isolated from Guizhi-Tang (GZT), which is a famous traditional Chinese medical formula used to treat influenza, common cold and other pyretic conditions. "( Effects of cinnamaldehyde on PGE2 release and TRPV4 expression in mouse cerebral microvascular endothelial cells induced by interleukin-1beta.
Guo, SY; Huo, HR; Jiang, TL; Li, CH; Li, LF; Ma, YY; Sui, F; Zhao, BS, 2008
)
2.18
"Cinnamaldehyde is a more potent skin sensitizer than cinnamic alcohol."( Human skin absorption and metabolism of the contact allergens, cinnamic aldehyde, and cinnamic alcohol.
Elahi, EN; Hotchkiss, SA; Moore, CA; Smart, AT; Smith, CK, 2000
)
1.03

Effects

Cinnamaldehyde (CM) has a molecular structure with the main reaction center of an aromatic ring. The bioactivity can be modified as an anticancer agent by substituting the groups in the ortho (o), meta (m), and para (p) position.

Cinnamaldehyde has been shown to inhibit the proliferation and inflammatory response of primary and immortalized immune cells. The bioactivity can be modified as an anticancer agent by substituting the groups in the ortho (o), meta (m), and para (p) position.

ExcerptReferenceRelevance
"Cinnamaldehyde has a potent anti-oxidant property."( Behavioral, histopathological, and biochemical evaluations on the effects of cinnamaldehyde, naloxone, and their combination in morphine-induced cerebellar toxicity.
Farshid, AA; Imani, M; Mahmoudi, S; Noroozinia, F; Tamaddonfard, E, 2022
)
1.67
"Cinnamaldehyde has a potential to replace the synthetic antimicrobial and/or antibiofilm agent as well as has a positive influence on consumer concern for the food safety issues of the poultry industries."( Investigating the antimicrobial and antibiofilm effects of cinnamaldehyde against Campylobacter spp. using cell surface characteristics.
Lee, NK; Paik, HD; Song, YJ; Yu, HH; Yu, HS, 2020
)
1.52
"Cinnamaldehyde (CM) has a molecular structure with the main reaction center of an aromatic ring which the bioactivity can be modified as an anticancer agent by substituting the groups in the ortho (o), meta (m), and para (p) position. "( Molecular Docking Compounds of Cinnamaldehyde Derivatives as Anticancer Agents.
Azzahra, VO; Murlistyarini, S; Sucahyo, A; Suratmo, S; Warsito, W, 2021
)
2.35
"Cinnamaldehyde (CA) has a protective effect in endotoxin poisoning of mice, but there is no direct evidence for the protective effect of CA through inhibition of NLRP3 inflammasome activation in endotoxin poisoning of mice."( Inhibition of NLRP3 inflammasome: a new protective mechanism of cinnamaldehyde in endotoxin poisoning of mice.
Sang, W; Wang, D; Wang, F; Wen, T; Xu, F; Zeng, N, 2017
)
2.14
"Cinnamaldehyde has been shown to exhibit multiple tumour-suppressing activities, but its role in human osteosarcoma is not yet completely defined."( Cinnamaldehyde decreases the invasion and u-PA expression of osteosarcoma by down-regulating the FAK signalling pathway.
Chen, PN; Chu, SC; Hsieh, YS; Hsu, LS; Lai, YA; Lin, CY, 2022
)
2.89
"Cinnamaldehyde (Ci) has many biological properties that include anti-inflammatory and antioxidant activities."( Cinnamaldehyde Mitigates Atherosclerosis Induced by High-Fat Diet
Abdel-Reheim, ES; Ali, TM; Elesawy, BH; Ismail, BS; Mahmoud, B; Soliman, HA; Zaky, MY, 2022
)
2.89
"Cinnamaldehyde has been successfully used for the short-term disinfection of dentures; however, its long-term effects on the surface and color properties of denture base materials remain unknown."( Effects of long-term cinnamaldehyde immersion on the surface roughness and color of heat-polymerized denture base resin.
Batista, AUD; Campos, DES; Carreiro, ADFP; da Nóbrega Alves, D; de Castro, RD; Macêdo, LO, 2022
)
2.48
"Cinnamaldehyde (CA) has demonstrated anti-inflammatory, anti-tumor and anti-cancer activities; Its antimicrobial and antibiofilm actions against Shigella flexneri, on the other hand, have not been investigated. "( Effects of cinnamaldehyde against planktonic bacteria and biofilm formation of Shigella flexneri.
Chang, Y; Cheng, X; Guo, D; Shi, C; Su, R; Tan, Y; Wang, M; Wang, R; Xia, X; Zhan, X, 2022
)
2.55
"Cinnamaldehyde has been widely applied in various fields due to its special flavor and various pharmacological activities, such as antioxidant, anti-inflammatory and antibacterial properties. "( Enrichment of cinnamaldehyde from Cinnamomum cassia by electroosmotic coupled particle-assisted solvent flotation.
Li, N; Wei, Y; Yan, C; Zhang, Y, 2023
)
2.71
"Cinnamaldehyde has a potent anti-oxidant property."( Behavioral, histopathological, and biochemical evaluations on the effects of cinnamaldehyde, naloxone, and their combination in morphine-induced cerebellar toxicity.
Farshid, AA; Imani, M; Mahmoudi, S; Noroozinia, F; Tamaddonfard, E, 2022
)
1.67
"Cinnamaldehyde has a potential to replace the synthetic antimicrobial and/or antibiofilm agent as well as has a positive influence on consumer concern for the food safety issues of the poultry industries."( Investigating the antimicrobial and antibiofilm effects of cinnamaldehyde against Campylobacter spp. using cell surface characteristics.
Lee, NK; Paik, HD; Song, YJ; Yu, HH; Yu, HS, 2020
)
1.52
"Cinnamaldehyde has previously been shown to activate sensory neurons via the selective gating of TRPA1."( Differential sensitivity of cinnamaldehyde-evoked calcium fluxes to ruthenium red in guinea pig and mouse trigeminal sensory neurons.
Bahia, PK; Taylor-Clark, TE, 2021
)
1.64
"Cinnamaldehyde (CIN) has been shown to inhibit the proliferation and inflammatory response of primary and immortalized immune cells."( Cinnamaldehyde inhibits psoriasis‑like inflammation by suppressing proliferation and inflammatory response of keratinocytes via inhibition of NF‑κB and JNK signaling pathways.
Ding, Z; Liu, J; Lv, M; Qian, H; Wu, L, 2021
)
2.79
"Cinnamaldehyde (CM) has a molecular structure with the main reaction center of an aromatic ring which the bioactivity can be modified as an anticancer agent by substituting the groups in the ortho (o), meta (m), and para (p) position. "( Molecular Docking Compounds of Cinnamaldehyde Derivatives as Anticancer Agents.
Azzahra, VO; Murlistyarini, S; Sucahyo, A; Suratmo, S; Warsito, W, 2021
)
2.35
"Cinnamaldehyde (CA) has been reported to exhibit anti-diabetic and anti-inflammatory properties."( Cinnamaldehyde Ameliorates Diet-Induced Obesity in Mice by Inducing Browning of White Adipose Tissue.
Fang, X; Gao, S; Liu, H; Ma, R; Ma, Y; Mo, F; Mu, Q; Wang, L; Wu, R; Yu, N; Zhang, D; Zhao, D; Zhu, R; Zuo, J, 2017
)
2.62
"Cinnamaldehyde (CA) has a protective effect in endotoxin poisoning of mice, but there is no direct evidence for the protective effect of CA through inhibition of NLRP3 inflammasome activation in endotoxin poisoning of mice."( Inhibition of NLRP3 inflammasome: a new protective mechanism of cinnamaldehyde in endotoxin poisoning of mice.
Sang, W; Wang, D; Wang, F; Wen, T; Xu, F; Zeng, N, 2017
)
2.14
"Cinnamaldehyde (CA) has various functional properties, such as anti-cancer, anti-microbial, anti-inflammatory, and anti-oxidant activities. "( Cinnamaldehyde protects human dental pulp cells against oxidative stress through the Nrf2/HO-1-dependent antioxidant response.
Ahn, SG; Kim, NY; Kim, SA, 2017
)
3.34
"Cinnamaldehyde (CIN) has been shown to exert chemopreventive activity against several types of human cancer cells. "( Cinnamaldehyde-induced apoptosis in human hepatoma PLC/PRF/5 cells involves the mitochondrial death pathway and is sensitive to inhibition by cyclosporin A and z-VAD-fmk.
Chang, SP; Chen, JL; Lin, CC; Lin, LT; Tai, CJ; Wu, SJ, 2013
)
3.28
"Cinnamaldehyde (CA) has been widely applied in medicine and food preservation. "( Cinnamaldehyde promotes root branching by regulating endogenous hydrogen sulfide.
Chen, J; Li, YQ; Qi, ZQ; Shi, Z; Xue, YF; Zhang, M, 2016
)
3.32
"Cinnamaldehyde has been reported to inhibit bacteria, yeasts, and filamentous molds via the inhibition of ATPases, cell wall biosynthesis, and alteration of membrane structure and integrity."( Cinnamaldehyde and its derivatives, a novel class of antifungal agents.
Ali, I; Behbehani, JM; Hun, LT; Irshad, M; Karched, M; Raja, V; Shreaz, S; Siddiqi, WA; Wani, WA, 2016
)
2.6
"Cinnamaldehyde has two independent biological activities; namely, an inhibitory action on AHR activation and an antioxidant effect mediated by NRF2/HO1 signaling. "( Inhibition of aryl hydrocarbon receptor signaling and induction of NRF2-mediated antioxidant activity by cinnamaldehyde in human keratinocytes.
Furue, M; Mitoma, C; Morino-Koga, S; Uchi, H; Yasumatsu, M, 2017
)
2.11
"Cinnamaldehyde (CA) has been known to exhibit anti-inflammatory and anticancer effects. "( Regulatory effect of cinnamaldehyde on monocyte/macrophage-mediated inflammatory responses.
Cho, JY; Kim, BH; Lee, J; Lee, JY; Lee, YG, 2010
)
2.12
"Cinnamaldehyde has previously been shown to inhibit QS-regulated virulence by decreasing the DNA-binding ability of the QS response regulator LuxR."( Structure-activity relationship of cinnamaldehyde analogs as inhibitors of AI-2 based quorum sensing and their effect on virulence of Vibrio spp.
Brackman, G; Celen, S; Coenye, T; Cos, P; Hillaert, U; Maes, L; Nelis, HJ; Van Calenbergh, S, 2011
)
1.37
"Cinnamaldehyde has been demonstrated to stimulate glutathione production and the expression of phase II detoxifying enzymes in HepG2 cells. "( Cinnamaldehyde enhances Nrf2 nuclear translocation to upregulate phase II detoxifying enzyme expression in HepG2 cells.
Chuang, SM; Chung, YL; Huang, TC; Wu, ML, 2011
)
3.25
"Cinnamaldehyde and camphor have been reported to be the major components of volatile oils from stem bark and root bark, respectively."( Chemistry, biogenesis, and biological activities of Cinnamomum zeylanicum.
Jayaprakasha, GK; Rao, LJ, 2011
)
1.09
"Cinnamaldehydes have been shown to have inhibitory effects on farnesyl protein transferase (FPTase; EC 2.5.1.29) in vitro, angiogenesis, cell-cell adhesion, and tumor cell growth and to be immunomodulators. "( Antitumor effect of the cinnamaldehyde derivative CB403 through the arrest of cell cycle progression in the G2/M phase.
Ha, JH; Han, DC; Han, MY; Jeong, HW; Kim, HC; Kim, HM; Kwon, BM; Lee, CW; Lim, JS; Son, KH, 2003
)
2.07
"Cinnamaldehyde has been used as a filtering agent and a rubber reinforcing agent and is used as a brightener in electroplating processes, as an animal repellent, as an insect attractant, and as an antifungal agent."( NTP toxicology and carcinogenesis studies of trans-cinnamaldehyde (CAS No. 14371-10-9) in F344/N rats and B6C3F1 mice (feed studies).
, 2004
)
1.3
"1. Cinnamaldehyde has been shown to be effective in inducing cell apoptosis in a number of human cancer cells. "( Effects of vitamin E on the cinnamaldehyde-induced apoptotic mechanism in human PLC/PRF/5 cells.
Lin, CC; Ng, LT; Wu, SJ, 2004
)
1.24
"Cinnamaldehyde (Cin) has been shown to be effective in inducing apoptotic cell death in a number of human cancer cells. "( Cinnamaldehyde-induced apoptosis in human PLC/PRF/5 cells through activation of the proapoptotic Bcl-2 family proteins and MAPK pathway.
Lin, CC; Ng, LT; Wu, SJ, 2005
)
3.21
"Cinnamaldehyde (CA) has been reported to inhibit in vitro aggregation in human and rabbit platelets; however, little is known about the antithrombotic activities of CA in vivo."( Cinnamaldehyde reduction of platelet aggregation and thrombosis in rodents.
Huang, J; Luo, X; Shi, X; Wang, S; Xie, Y, 2007
)
3.23

Actions

Cinnamaldehyde did not inhibit the activation of NFkappaB or IRF3 induced by MyD88-dependent (MyD88, IKKbeta) or TRIF- dependent (TRIF, TBK1) downstream signaling components. It could inhibit invasive capabilities of human breast cancer cell line MDA-MB-435S.

ExcerptReferenceRelevance
"Cinnamaldehyde can suppress CAF T-cell inhibition."( Cinnamaldehyde Treatment of Prostate Cancer-Associated Fibroblasts Prevents Their Inhibitory Effect on T Cells Through Toll-Like Receptor 4.
Hu, M; Ma, F; Ma, J; Mei, J; Qin, Z; Tao, N; Wang, Y; Xu, Y; Xue, R, 2020
)
2.72
"Cinnamaldehyde could inhibit invasive capabilities of human breast cancer cell line MDA-MB-435S. "( [Inhibitory effect of cinnamaldehyde on invasion capacities of human breast cancer cell line MDA-MB-435S and its relation with regulating the expression of miR-27a].
Sun, QM; Wang, G; Wang, RP; Wu, J; Zou, X, 2014
)
2.16
"Cinnamaldehyde and nicotine activate the transient receptor potential subtype A1 (TRPA1) channel, which may cause burning sensations. "( Interaction between intra-oral cinnamaldehyde and nicotine assessed by psychophysical and physiological responses.
Andersen, MV; Arendt-Nielsen, L; Boudreau, SA; Jensen, TK; Nielsen, KA, 2016
)
2.16
"Cinnamaldehyde did not inhibit the activation of NFkappaB or IRF3 induced by MyD88-dependent (MyD88, IKKbeta) or TRIF-dependent (TRIF, TBK1) downstream signaling components."( Cinnamaldehyde suppresses toll-like receptor 4 activation mediated through the inhibition of receptor oligomerization.
Choi, YJ; Hwang, DH; Lee, JK; Lee, JY; Miyake, K; Saitoh, SI; Youn, HS, 2008
)
2.51
"cinnamaldehyde, an exceeding increase in this parameter was obtained during the later period of time course."( Pharmacological studies on Chinese cinnamon. V. Catecholamine releasing effect of cinnamaldehyde in dogs.
Harada, M; Hirayama, Y; Yamazaki, R, 1982
)
1.21

Treatment

Cinnamaldehyde or curcumin treatment increased Akt2 phosphorylation at multiple sites including T450 and Y475, but had no effect on Akt 2 phosphorylated at S474. CinnAmaldehyde treatment reduced periodontal bone loss and downregulated key inflammatory mediators and human PBMC responses.

ExcerptReferenceRelevance
"Cinnamaldehyde or curcumin treatment increased Akt2 phosphorylation at multiple sites including T450 and Y475, but had no effect on Akt2 phosphorylation at S474, which is critical for Akt2 activation."( Cinnamaldehyde and Curcumin Prime Akt2 for Insulin-Stimulated Activation.
Le, TT; Urasaki, Y, 2022
)
2.89
"Cinnamaldehyde treatment reduced periodontal bone loss, and downregulated key inflammatory mediators and human PBMC responses, pointing to novel potential therapeutic effects of this compound."( Cinnamaldehyde modulates host immunoinflammatory responses in rat ligature-induced periodontitis and peripheral blood mononuclear cell models.
Aguiar-da-Silva, LD; Branco-de-Almeida, LS; Cardoso, CRB; de Oliveira, ICV; Duarte-Silva, M; Fernandes, ES; Galvão-Moreira, LV; Lima-Neto, LG; Pereira, CAA; Pereira, DMS; Pinheiro, AJMCR; Vilela, JL, 2023
)
3.07
"Cinnamaldehyde-treated adolescent rats showed less weight gain (P = 0.041), improved OGTT (P = 0.004), increased expression of phosphorylated IRS-1 (P = 0.015), and a trend to increase phosphorylated IRS-1 (P = 0.063) in the liver of adolescent rats in the basal state. "( Cinnamaldehyde supplementation acts as an insulin mimetic compound improving glucose metabolism during adolescence, but not during adulthood, in healthy male rats.
Bento-Bernardes, T; Boechat, SK; Gaique, TG; Medeiros, RF; Neto, JGO; Oliveira, KJ; Pazos-Moura, CC, 2023
)
3.8
"Cinnamaldehyde-treated microcultures showed impaired cellular development, with an expression of rare pseudo-hyphae and absence of chlamydoconidia."( Docking Prediction, Antifungal Activity, Anti-Biofilm Effects on
Abílio, GMF; Andrade, PN; Castro, RD; da Nóbrega Alves, D; Guerra, FQS; Lazarini, JG; Monteiro, AFM; Rosalen, PL; Scotti, L; Scotti, MT, 2020
)
1.28
"Cinnamaldehyde treatment reduced the number of attached cells in polypropylene, reflected by colony count and scanning electron microscopy."( Cinnamaldehyde induces changes in the protein profile of Salmonella Typhimurium biofilm.
Cardoso, RF; Coelho Trevisan, DA; de Abreu Filho, BA; de Souza, EM; Dos Santos, AR; Estivalet Svidzinski, TI; Graton Mikcha, JM; Junior, MM; Kukolj, C; Ribeiro, AB; Silva, AF; Zanetti Campanerut-Sá, PA, 2018
)
2.64
"Cinnamaldehyde treatment significantly decreased inflammatory cytokine (TNF-α, IL-6, NO and MCP-1) overproduction and the serum lipid level."( Cinnamaldehyde attenuates atherosclerosis via targeting the IκB/NF-κB signaling pathway in high fat diet-induced ApoE
Li, W; Liu, F; Niu, X; Zang, L; Zhao, J; Zhi, W, 2019
)
2.68
"Cinnamaldehyde treatment of gliadin films provided a means of decreasing their solubility, increasing their molecular weight profile, and reducing their overall migration into food simulants as a consequence of the high degree of polymerization achieved. "( Retention and release of cinnamaldehyde from wheat protein matrices.
Balaguer, MP; Borne, M; Chalier, P; Gavara, R; Gontard, N; Hernandez-Munoz, P; Morel, MH; Peyron, S, 2013
)
2.14
"Cinnamaldehyde treatment induced the generation of peroxynitrite that was blocked by the peroxynitrite scavenger FeTPPS and shown to be dependent on TRPA1, as reflected by an increase in protein tyrosine nitration in the skin of WT, but not in TRPA1 KO mice."( TRPA1 activation leads to neurogenic vasodilatation: involvement of reactive oxygen nitrogen species in addition to CGRP and NO.
Abdul-Kader, N; Aubdool, AA; Bevan, S; Brain, SD; Fernandes, ES; Heads, R; Kodji, X, 2016
)
1.16
"Cinnamaldehyde treatment inhibited the browning of cut lettuce during cold storage. "( Cinnamaldehyde inhibits enzymatic browning of cut lettuce by repressing the induction of phenylalanine ammonia-lyase without promotion of microbial growth.
Hosaka, H; Murata, M; Okumura, S; Shimamura, Y; Takamiya, R; Tanaka, E, 2011
)
3.25
"Cinnamaldehyde treatment of E."( Disruption of Escherichia coli, Listeria monocytogenes and Lactobacillus sakei cellular membranes by plant oil aromatics.
Gill, AO; Holley, RA, 2006
)
1.06
"Treatment with cinnamaldehyde was effective in providing neuroprotection and attenuating cerebral vasospasm after subarachnoid hemorrhage in rabbits."( The effects of Cinnamaldehyde on early brain injury and cerebral vasospasm following experimental subarachnoid hemorrhage in rabbits.
Arıkök, AT; Bozkurt, H; Çelikoğlu, E; Gürer, B; Karakoç, A; Kertmen, H; Kuru Bektaşoğlu, P; Öztürk, ÖÇ, 2019
)
1.21
"Treatment with cinnamaldehyde led to inhibition of cell viability, proliferation and induced apoptosis in a dose-dependent manner in primary and immortalized immune cells."( Immune suppressive effect of cinnamaldehyde due to inhibition of proliferation and induction of apoptosis in immune cells: implications in cancer.
Diaz-Perales, A; Fuchs, HC; Gomez-Casado, C; Jensen-Jarolim, E; Kinaciyan, T; Moskovskich, A; Oida, K; Roth-Walter, F; Singer, J, 2014
)
1.03
"Treatment with cinnamaldehyde not only attenuated caspase-3 activation and the caspase cleavage cascade in DRG neurons, but also lowered the elevated IL-6, TNF-α, cyclo-oxygenase and inducible nitric oxide synthase levels, indicating a reduction in inflammatory damage."( Anti-oxidative and anti-inflammatory effects of cinnamaldehyde on protecting high glucose-induced damage in cultured dorsal root ganglion neurons of rats.
Liang, XC; Liu, D; Liu, W; Shi, Y; Sun, Q; Yang, D; Zhang, H, 2016
)
1.03
"Pretreatment of cinnamaldehyde with thiol-containing compounds, such as β-mercaptoethanol or cysteine, blocked the inhibitory activity of cinnamaldehyde."( Effects of cinnamaldehyde on the glucose transport activity of GLUT1.
Bushhouse, KT; Cok, A; Louters, LL; Opejin, A; Plaisier, C; Salie, MJ; Scott, J, 2011
)
1.09
"Treatment with cinnamaldehyde could improve the sensory properties and extend the shelf life of Pacific white shrimp to 8 days. "( Effect of cinnamaldehyde on melanosis and spoilage of Pacific white shrimp (Litopenaeus vannamei) during storage.
Chen, H; Fang, X; Gao, H; Mao, J; Mu, H, 2012
)
1.13
"When treated with cinnamaldehyde for 10 weeks, hepatic tumor development was delayed with 2'-benzoyloxycinnamaldehyde (BCA) compared with control hepatocellular carcinoma formation."( Delayed occurrence of H-ras12V-induced hepatocellular carcinoma with long-term treatment with cinnamaldehydes.
Kim, HC; Kim, HM; Kim, JM; Kwon, BM; Lee, JH; Lee, MR; Moon, EY; Wang, AG; Yu, DY, 2006
)
0.88

Toxicity

Cinnamaldehyde was effective and safe in treating immunosuppressed BALB/c mice with invasive pulmonary candidiasis. In contact plus fumigant mortality bioassays, the most toxic compounds were (E)-cinn amaldehyde, methyl (E) cinnamate, cinnamyl acetate, and hydrocinnAmaldehyde against adult D.

ExcerptReferenceRelevance
" The related aldehyde, alcohol and esters are all more toxic than cinnamic acid."( The occurrence, metabolism and toxicity of cinnamic acid and related compounds.
Hoskins, JA, 1984
)
0.27
" These results demonstrate that microencapsulation in feed can present a useful alternative to gavage dosing for repeated-dose or prolonged-exposure studies, in that (1) the toxic effects of CNMA were similar after gavage dosing and after administration in microencapsulated form in feed, (2) ingestion of chemical in the feed more closely approximates human exposures, and (3) microencapsulation allows the delivery of higher net doses of chemical, while avoiding the acutely toxic effects of a bolus dose."( Comparison of the toxicity of cinnamaldehyde when administered by microencapsulation in feed or by corn oil gavage.
Dieter, MP; Hébert, CD; Yuan, J, 1994
)
0.58
" In conclusion, the considered in vitro cytotoxicity assays have shown to be sensitive enough to highlight a variety of toxic effects at the cellular level, which can be rather different between chemically closely related compounds, such as isomers."( Toxicity of selected plant volatiles in microbial and mammalian short-term assays.
Alakomi, HL; Bonsi, P; Moezelaar, R; Stammati, A; von Wright, A; Zucco, F, 1999
)
0.3
" Based on 48-h LD50 values, the toxicity of allyl cinnmate (0."( Toxicity of cassia and cinnamon oil compounds and cinnamaldehyde-related compounds to Sitophilus oryzae (Coleoptera: Curculionidae).
Ahn, YJ; Choi, DR; Kim, JR; Lee, EJ, 2008
)
0.6
" Based on 24-h LC50 values, binary mixtures of Bti and CA, AN, or EU were significantly more toxic against Ae."( Enhanced toxicity of binary mixtures of Bacillus thuringiensis subsp. israelensis and three essential oil major constituents to wild Anopheles sinensis (Diptera: Culicidae) and Aedes albopictus (Diptera: Culicidae).
Ahn, YJ; Chang, KS; Shin, EH; Yoo, DH, 2014
)
0.4
" At LC50, CINA was the most toxic (0."( In vitro safety assessment of food ingredients in canine renal proximal tubule cells.
Jeffery, B; Koči, J; Monteiro-Riviere, NA; Riviere, JE, 2015
)
0.42
" The LD50 values of CA and SME-CA in mice were 74."( Cinnamaldehyde in a Novel Intravenous Submicrometer Emulsion: Pharmacokinetics, Tissue Distribution, Antitumor Efficacy, and Toxicity.
Cao, W; Wang, S; Xie, Y; Yang, Q; Yuan, J; Zhao, H, 2015
)
1.86
"Aflatoxins (AF) are toxic metabolites produced by molds, Aspergillus flavus and Aspergillus parasiticus, which frequently contaminate poultry feed ingredients."( Phytochemicals reduce aflatoxin-induced toxicity in chicken embryos.
Chen, CH; Darre, MJ; Donoghue, AM; Donoghue, DJ; Venkitanarayanan, K; Yin, HB, 2017
)
0.46
" Several studies have suggested opioid antagonist and antioxidant therapy for reducing adverse effects of morphine."( Behavioral, histopathological, and biochemical evaluations on the effects of cinnamaldehyde, naloxone, and their combination in morphine-induced cerebellar toxicity.
Farshid, AA; Imani, M; Mahmoudi, S; Noroozinia, F; Tamaddonfard, E, 2022
)
0.95
" In the final step, samples and single-aroma standards were tested for their toxicity to HUVEC/Tert2 cells, where some single-flavoring chemicals such as cinnamic aldehyde revealed significant toxic effects."( Quantification of selected aroma compounds in e-cigarette products and toxicity evaluation in HUVEC/Tert2 cells.
Bonn, G; Gstir, R; Noël, JC; Rainer, D; Rainer, M, 2020
)
0.56
"Cinnamaldehyde was effective and safe in treating immunosuppressed BALB/c mice with invasive pulmonary candidiasis."( Effect and Safety of Cinnamaldehyde on Immunosuppressed Mice with Invasive Pulmonary Candidiasis.
Deng, JH; Li, JH; Wang, GS; Zhao, YL, 2021
)
2.38
"The ointment is safe and tolerable for use on healthy oral mucosa."( Safety and tolerability of cinnamaldehyde in orabase for oral candidiasis treatment: phase I clinical trial.
Alves, AF; da Nóbrega Alves, D; da Silva Araújo, R; de Araújo, MRC; de Castro, RD; Melo, AKV, 2022
)
1.02
"The ointment proved to be safe and tolerable for use on oral mucosa, encouraging studies to evaluate its clinical efficacy in patients with oral candidiasis, and contributing to a new therapeutic proposal for the treatment of fungal infections caused by Candida spp."( Safety and tolerability of cinnamaldehyde in orabase for oral candidiasis treatment: phase I clinical trial.
Alves, AF; da Nóbrega Alves, D; da Silva Araújo, R; de Araújo, MRC; de Castro, RD; Melo, AKV, 2022
)
1.02
" Moreover, they were not toxic to the non-target fishes."( Ovicidal toxicity of plant essential oils and their major constituents against two mosquito vectors and their non-target aquatic predators.
Aungtikun, J; Moungthipmalai, T; Puwanard, C; Sittichok, S; Soonwera, M, 2023
)
0.91

Pharmacokinetics

ExcerptReferenceRelevance
" Furthermore, the sensitivity of gas chromatography-mass spectrometry revealed sufficient lower limit of quantitation and detection of 20ng/ml and 5ng/ml, respectively, in the pharmacokinetic analysis."( Pharmacokinetic study of cinnamaldehyde in rats by GC-MS after oral and intravenous administration.
Cao, W; Cao, Y; Tu, H; Wang, S; Xie, Y; Yang, Q; Zhao, H, 2014
)
0.71
" The new formulation exhibited lower toxicity, higher antitumor activity, and a more satisfactory pharmacokinetic property, which displayed great potential for future pharmacological application."( Cinnamaldehyde in a Novel Intravenous Submicrometer Emulsion: Pharmacokinetics, Tissue Distribution, Antitumor Efficacy, and Toxicity.
Cao, W; Wang, S; Xie, Y; Yang, Q; Yuan, J; Zhao, H, 2015
)
1.86
" In order to characterize their pharmacokinetic profiles and aptitude to permeate in the central nervous system after intravenous and oral administration to rats, new analytical procedures, easily achievable with HPLC-UV techniques, were developed."( Pharmacokinetic and Permeation Studies in Rat Brain of Natural Compounds Led to Investigate Eugenol as Direct Activator of Dopamine Release in PC12 Cells.
Bianchi, A; Botti, G; Dalpiaz, A; Ferraro, L; Pavan, B; Spisni, E; Valerii, MC, 2023
)
0.91

Compound-Compound Interactions

Cinnamon essential oil and cinnamaldehyde, either used alone or in combination with EDTA, were effective against the causative micro-organisms of canine otitis externa.

ExcerptReferenceRelevance
"The cell-inactivating effect induced by cinnamaldehyde in combination with cis-diamminedichloroplatinum(II) (cis-DDP) on human NHIK 3025 cells in culture was investigated."( Synergistic cell inactivation of human NHIK 3025 cells by cinnamaldehyde in combination with cis-diamminedichloroplatinum(II).
Dornish, JM; Oftebro, R; Pettersen, EO, 1988
)
0.79
"We examined the therapeutic effects of cinnamaldehyde and the potentiation of those effects with cassia and cinnamaldehyde when combined with the food additive methylcellulose against murine oral candidiasis."( Therapeutic effects of cinnamaldehyde and potentiation of its efficacy in combination with methylcellulose on murine oral candidiasis.
Abe, S; Arai, R; Hayama, K; Okada, M; Sagawa, T; Taguchi, Y, 2011
)
0.95
" In combination with HPLC-HRMS-SPE-NMR, this provides an analytical platform that allows simultaneous chemical and biological profiling of α-amylase inhibitors in plant extracts."( High-resolution α-amylase assay combined with high-performance liquid chromatography-solid-phase extraction-nuclear magnetic resonance spectroscopy for expedited identification of α-amylase inhibitors: proof of concept and α-amylase inhibitor in cinnamon.
Jäger, AK; Kongstad, KT; Okutan, L; Staerk, D, 2014
)
0.4
" The aim of this study was to investigate the ability of semipurified preparations (SPP) containing either nisin A or an enhanced bioengineered derivative, nisin V, alone and in combination with low concentrations of the essential oils thymol, carvacrol, and trans-cinnamaldehyde, to control Listeria monocytogenes in both laboratory media and model food systems."( Efficacies of nisin A and nisin V semipurified preparations alone and in combination with plant essential oils for controlling Listeria monocytogenes.
Cotter, PD; Daly, K; Field, D; Hill, C; O'Connor, PM; Ross, RP, 2015
)
0.6
" Cinnamon bark oil and cinnamaldehyde combined with colistin demonstrated synergistic rates at 16."( Efficacy of cinnamon bark oil and cinnamaldehyde on anti-multidrug resistant Pseudomonas aeruginosa and the synergistic effects in combination with other antimicrobial agents.
Chomnawang, MT; Jaturanpinyo, M; Khuntayaporn, P; Surassmo, S; Utchariyakiat, I, 2016
)
1.02
"The antimicrobial activity of cinnamon essential oil and cinnamaldehyde against bacterial and fungal pathogens associated with canine otitis externa, as well as the effect of their combination with EDTA were investigated."( Antimicrobial effects of cinnamon essential oil and cinnamaldehyde combined with EDTA against canine otitis externa pathogens.
Deo, P; Khazandi, M; Pi, H; Sim, JXF; Trott, DJ; Venter, H, 2019
)
1.01
"Cinnamon essential oil and cinnamaldehyde, either used alone or in combination with EDTA, were effective against the causative micro-organisms of canine otitis externa."( Antimicrobial effects of cinnamon essential oil and cinnamaldehyde combined with EDTA against canine otitis externa pathogens.
Deo, P; Khazandi, M; Pi, H; Sim, JXF; Trott, DJ; Venter, H, 2019
)
1.06
"This study shows that cinnamon essential oil and cinnamaldehyde, especially the latter, could be used in combination with EDTA as novel treatment for sensitive and resistant bacterial and fungal pathogens involved in canine otitis externa."( Antimicrobial effects of cinnamon essential oil and cinnamaldehyde combined with EDTA against canine otitis externa pathogens.
Deo, P; Khazandi, M; Pi, H; Sim, JXF; Trott, DJ; Venter, H, 2019
)
1.02
"Effects of lysozyme (LYS) combined with cinnamaldehyde (CA) on quality enhancement of olive flounder (Paralichthys olivaceus) fillets during refrigerated storage at 4 °C for 20 days were assessed."( Effects of lysozyme combined with cinnamaldehyde on storage quality of olive flounder (Paralichthys olivaceus) fillets.
Li, J; Li, T; Li, X; Sun, T; Xu, Y; Yin, Y; Zhao, H, 2020
)
1.1

Bioavailability

The purpose of this experiment was to explore the effect of Solid lipid nanoparticles (SLNs) on improving the oral absorption and bioavailability of cinnamaldehyde (CA) Trans-cinn amaldehyde as a natural antibacterial compound was used to prepare nano size emulsions to increase its bioavailability.

ExcerptReferenceRelevance
" The estimated oral bioavailability of CNMA was less than 20% for both the 250 and 500 mg/kg doses."( Toxicokinetics of cinnamaldehyde in F344 rats.
Bucher, JR; Dieter, MP; Jameson, CW; Yuan, JH, 1992
)
0.62
"The choice of vehicle for patch test materials is important for the bioavailability and stability of the allergens."( Aspects of pharmaceutical and chemical standardization of patch test materials.
Hansen, J; Kreilgård, B, 1989
)
0.28
"The bioavailability of microencapsulated cinnamaldehyde (CNMA) was investigated in male F344 rats."( Application of microencapsulation for toxicology studies. III. Bioavailability of microencapsulated cinnamaldehyde.
Bucher, JR; Dieter, MP; Jameson, CW; Yuan, J, 1993
)
0.77
" However, its hydrophobic nature invites attention for efficient drug delivery systems that would enhance the bioavailability of cinnamaldehyde without affecting its bioactivity."( Synthesis, characterization and in vitro study of biocompatible cinnamaldehyde functionalized magnetite nanoparticles (CPGF Nps) for hyperthermia and drug delivery applications in breast cancer.
Chikate, RC; Deore, AV; Dhole, SD; Gupta, P; Kadu, BS; Kaul-Ghanekar, R; Mansara, P; Poddar, P; Wani, KD, 2014
)
0.85
"Using ultrasonic technology, trans-cinnamaldehyde as a natural antibacterial compound was used to prepare nano size emulsions to increase its bioavailability and therefore bactericidal action."( Ultrasonic nanoemulsification of food grade trans-cinnamaldehyde: 1,8-Cineol and investigation of the mechanism of antibacterial activity.
Aliahmadi, A; Moghimi, R; Rafati, H, 2017
)
0.99
" Microencapsulation of BEOs has shown to improve their stability, bioavailability and to control their release rate once they are added to the feedstuff."( Determination of cinnamaldehyde, carvacrol and thymol in feedstuff additives by pressurized liquid extraction followed by gas chromatography-mass spectrometry.
Jiménez-Salcedo, M; Tena, MT, 2017
)
0.79
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
"The oral bioavailability of tangeretin, a poly(methoxyflavone) found in citrus fruits, is typically very low because of its extremely limited solubility."( Biopolymer Additives Enhance Tangeretin Bioavailability in Emulsion-Based Delivery Systems: An
Hu, Y; Li, B; Li, Y; Liu, F; McClements, DJ; Pang, J; Zhou, Z, 2021
)
0.62
"The current investigation explores the possible mechanism of the microemulsion drug delivery system to improve the oral bioavailability of cinnamaldehyde (CA), an important food spice, from the perspective of the microemulsion-mucus system."( In vitro and in vivo evaluation of cinnamaldehyde Microemulsion-Mucus interaction.
Cai, Y; Chen, J; Chu, X; Dong, B; Wu, W, 2022
)
1.2
"The purpose of this experiment was to explore the effect of Solid lipid nanoparticles (SLNs) on improving the oral absorption and bioavailability of cinnamaldehyde (CA)."( Improved uptake and bioavailability of cinnamaldehyde
Chu, X; Meng, Y; Wu, L; Xu, Y, 2022
)
1.19
"It was concluded that CA-SLNs improved the absorption across Caco-2 cell model and improved the oral administration bioavailability of CA in rats."( Improved uptake and bioavailability of cinnamaldehyde
Chu, X; Meng, Y; Wu, L; Xu, Y, 2022
)
0.99

Dosage Studied

We evaluated the extent of synergy that a combination of silver nanoparticles and an essential oil representative could offer. Trans-cinnamaldehyde was chosen as test substance and applied in a suitable dosing vehicle on dermatomed human skin sections. No increase in the frequency of micronucleated erythrocytes was observed in peripheral blood of male or female mice administered trans-c Kinnamaldehyde in dosed feed for 3 months.

ExcerptRelevanceReference
" No CNMA was present in blood at any time in rats dosed with 50 mg CNMA/kg body weight."( Toxicokinetics of cinnamaldehyde in F344 rats.
Bucher, JR; Dieter, MP; Jameson, CW; Yuan, JH, 1992
)
0.62
"Rats dosed with cinnamic aldehyde (I) excreted two mercapturic acids in the urine."( Isolation and identification of mercapturic acids of cinnamic aldehyde and cinnamyl alcohol from urine of female rats.
Delbressine, LP; Klippert, PJ; Reuvers, JT; Seuttler-Berlage, F, 1981
)
0.26
"The toxicity of cinnamaldehyde (CNMA) was compared after administration by gavage and in dosed feed."( Comparison of the toxicity of cinnamaldehyde when administered by microencapsulation in feed or by corn oil gavage.
Dieter, MP; Hébert, CD; Yuan, J, 1994
)
0.92
" At all dose levels, a small amount of the dose was distributed to the fat and was easily measured in animals killed 3 days after dosing at the 50 or 500 mg/kg dose levels."( Tissue distribution and excretion of 14C-labelled cinnamic aldehyde following single and multiple oral administration in male Fischer 344 rats.
Dailey, RE; Ikeda, GJ; Lin, CS; Plummer, SL; Sapienza, PP; Warr, PI, 1993
)
0.29
" No increase in the frequency of micronucleated erythrocytes was observed in peripheral blood of male or female mice administered trans-cinnamaldehyde in dosed feed for 3 months."( NTP toxicology and carcinogenesis studies of trans-cinnamaldehyde (CAS No. 14371-10-9) in F344/N rats and B6C3F1 mice (feed studies).
, 2004
)
0.78
" All rats survived to the end of the study but some male mice in the highest dose groups died due to inanition from unpalatability of the dosed feed."( Toxicology and carcinogenesis studies of microencapsulated trans-cinnamaldehyde in rats and mice.
Bucher, JR; Burka, LT; Fuciarelli, AF; Graves, SW; Haseman, JK; Hooth, MJ; Johnson, JD; Orzech, DP; Sills, RC; Witt, KL, 2004
)
0.56
" A time-course series of tissues from tuberculosis infected/INH dosed animals were assayed and the MALDI MS/MS response correlates well with the amount of INH determined to be in the tissues by high-performance liquid chromatography (HPLC)-MS/MS."( Reagent precoated targets for rapid in-tissue derivatization of the anti-tuberculosis drug isoniazid followed by MALDI imaging mass spectrometry.
Barry, CE; Caprioli, RM; Dartois, V; Goh, A; Manier, ML; Reyzer, ML; Via, LE, 2011
)
0.37
" Trans-cinnamaldehyde was chosen as test substance and applied in a suitable dosing vehicle on dermatomed human skin sections."( Application of liquid chromatography-direct-electron ionization-MS in an in vitro dermal absorption study: quantitative determination of trans-cinnamaldehyde.
Cappiello, A; Famiglini, G; Jacquoilleot, S; Radici, L; Saib, O; Termopoli, V; Trufelli, H; Zazzeroni, R, 2011
)
1.03
" At d 1, before placement, half of the birds from each pen were tagged and dosed with Salmonella enterica serovar Heidelberg (5 × 10(5) cfu/mL)."( Effect of xylanase and a blend of essential oils on performance and Salmonella colonization of broiler chickens challenged with Salmonella Heidelberg.
Amerah, AM; Hofacre, CL; Mathis, G, 2012
)
0.38
" With the aim of exploring combinatorial options that could increase the antibacterial potency of silver nanoparticles and reduce the effective dosage of silver, we evaluated the extent of synergy that a combination of silver nanoparticles and an essential oil representative (cinnamaldehyde) could offer."( Synergistic action of cinnamaldehyde with silver nanoparticles against spore-forming bacteria: a case for judicious use of silver nanoparticles for antibacterial applications.
Ghosh, IN; Navani, NK; Pathania, R; Patil, SD; Sharma, TK; Srivastava, SK, 2013
)
0.88
" To assess interaction of skin sensitizers in a mixture, a dose-response modeling approach is applied."( A Dose-Response Modeling Approach Shows That Effects From Mixture Exposure to the Skin Sensitizers Isoeugenol and Cinnamal Are in Line With Dose Addition and Not With Synergism.
Ezendam, J; Gremmer, ER; Kienhuis, AS; Slob, W; Vermeulen, JP, 2015
)
0.42
" A greater therapeutic role was observed for the 4 mg/kgBW dosage of the methanolic extract (p < 0."( Immunomodulatory and therapeutic role of Cinnamomum verum extracts in collagen-induced arthritic BALB/c mice.
Anjum, S; Ashraf, MU; Bhatti, A; John, P; Qadir, MMF; Sandhu, MA, 2018
)
0.48
" hBE cells were subsequently exposed to various concentrations of cinnamaldehyde to establish a dose-response relationship for effects on CBF."( Cinnamaldehyde in flavored e-cigarette liquids temporarily suppresses bronchial epithelial cell ciliary motility by dysregulation of mitochondrial function.
Carson, JL; Clapp, PW; Jaspers, I; Lavrich, KS; Lazarowski, ER; van Heusden, CA, 2019
)
2.19
" albicans infection were given an oral dosage of CA (240 mg."( Effect of Cinnamaldehyde on C. albicans cell wall and (1,3)- β - D-glucans in vivo.
Deng, JH; Li, YL; Luo, JN; Qi, XM; Wang, GS; Wang, J; Zhang, XG, 2022
)
1.12
" Based on muscle crude protein content, optimal CIN supplementation dosage was 88."( Dietary cinnamaldehyde improves muscle protein content by promoting muscle fiber growth via PTP1B/IGF1/PI3K/AKTs-TOR/FOXO3a signaling pathway in grass carp (Ctenopharyngodon idella).
Feng, L; Jiang, WD; Kuang, SY; Li, SW; Liu, Y; Peng, Y; Tang, L; Wu, P; Zhou, XQ; Zhou, Y, 2023
)
1.34
" These results partly explain the advantages of using whole essential oils over isolated ingredients, and therefore support the application of traditional dosage forms for bacterial infections in ethnomedicine."( Short communication: Antibacterial effects of essential oils from Cinnamomum cassia bark and Eucalyptus globulus leaves-The involvements of major constituents.
Hoang, HT; Miyamoto, A; Nguyen, HT; Nguyen, HTT; Pham, HT; Tong, NTM; Truong, LTN, 2023
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (7)

RoleDescription
hypoglycemic agentA drug which lowers the blood glucose level.
EC 4.3.1.24 (phenylalanine ammonia-lyase) inhibitorAn EC 4.3.* (C-N lyase) inhibitor that interferes with the action of phenylalanine ammonia-lyase (EC 4.3.1.24).
vasodilator agentA drug used to cause dilation of the blood vessels.
antifungal agentAn antimicrobial agent that destroys fungi by suppressing their ability to grow or reproduce.
flavouring agentA food additive that is used to added improve the taste or odour of a food.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
sensitiserA chemical compound that causes a substantial proportion of exposed people or animals to develop an allergic reaction in normal tissue after repeated exposure to the compound.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
cinnamaldehydesAn enal based on a cinnamaldehyde skeleton and its substituted derivatives.
3-phenylprop-2-enalA member of the class of cinnamaldehydes that is prop-2-enal in which a hydrogen at position 3 has been replaced by a phenyl group. The configuration of the double bond is not specified; the name "cinnamaldehyde" is widely used to refer to the E (trans) isomer.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (36)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency44.78530.007215.758889.3584AID1224835
interleukin 8Homo sapiens (human)Potency70.90110.047349.480674.9780AID651758
acetylcholinesteraseHomo sapiens (human)Potency49.98250.002541.796015,848.9004AID1347397; AID1347398
RAR-related orphan receptor gammaMus musculus (house mouse)Potency25.82120.006038.004119,952.5996AID1159521; AID1159523
GLI family zinc finger 3Homo sapiens (human)Potency10.80050.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency32.43120.000221.22318,912.5098AID1259243; AID1259247; AID743036; AID743040; AID743053
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency7.55060.011212.4002100.0000AID1030
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency45.70290.001022.650876.6163AID1224838; AID1224839; AID1224893
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency34.59250.003041.611522,387.1992AID1159552; AID1159553; AID1159555
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency29.78820.001530.607315,848.9004AID1224841; AID1259401; AID1259403
pregnane X nuclear receptorHomo sapiens (human)Potency61.87100.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency35.90650.000229.305416,493.5996AID1259244; AID743069; AID743075; AID743079; AID743080; AID743091
67.9K proteinVaccinia virusPotency22.38720.00018.4406100.0000AID720579
shiga toxin 1 variant A subunitEscherichia coli O157:H7Potency10.02395.035416.193232.6037AID2318; AID2320
shiga toxin 1 B subunitEscherichia coli O157:H7Potency10.02395.035413.848822.4921AID2318; AID2320
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency43.64650.001024.504861.6448AID743215
IDH1Homo sapiens (human)Potency29.09290.005210.865235.4813AID686970
aryl hydrocarbon receptorHomo sapiens (human)Potency64.86010.000723.06741,258.9301AID743085; AID743122
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency28.62060.001723.839378.1014AID743083
parathyroid hormone/parathyroid hormone-related peptide receptor precursorHomo sapiens (human)Potency112.20203.548119.542744.6684AID743266
mitogen-activated protein kinase 1Homo sapiens (human)Potency39.81070.039816.784239.8107AID995
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency62.93350.000627.21521,122.0200AID651741; AID720636; AID743202
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency12.58930.00798.23321,122.0200AID2546
gemininHomo sapiens (human)Potency0.14580.004611.374133.4983AID624297
peripheral myelin protein 22Rattus norvegicus (Norway rat)Potency18.10560.005612.367736.1254AID624032
lamin isoform A-delta10Homo sapiens (human)Potency0.63100.891312.067628.1838AID1487
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency30.63790.001557.789015,848.9004AID1259244
Cellular tumor antigen p53Homo sapiens (human)Potency42.12340.002319.595674.0614AID651631
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency30.63790.001551.739315,848.9004AID1259244
Nuclear receptor ROR-gammaHomo sapiens (human)Potency37.57800.026622.448266.8242AID651802
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Polyphenol oxidase 2Agaricus bisporusIC50 (µMol)520.00000.03403.987110.0000AID467606
Polyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)IC50 (µMol)35.00000.00011.68479.3200AID1603728
Cell division protein FtsZEscherichia coli K-12IC50 (µMol)6.33505.81007.556710.0000AID1201462; AID1201463
Prostaglandin G/H synthase 2Homo sapiens (human)IC50 (µMol)245.00000.00010.995010.0000AID403340
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Transient receptor potential cation channel subfamily A member 1Homo sapiens (human)EC50 (µMol)18.88230.00033.166210.0000AID1549771; AID329099; AID452237; AID482140
Transient receptor potential cation channel subfamily A member 1Mus musculus (house mouse)EC50 (µMol)61.00000.40002.771410.0000AID1549782
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Transient receptor potential cation channel subfamily A member 1Homo sapiens (human)Activity10.00000.09908.019810.0000AID500219
Cell division protein FtsZEscherichia coli K-12INH6.31005.81008.125010.0000AID1628114; AID1628120
Cell division protein FtsZEscherichia coli K-12Ka1.00001.00001.00001.0000AID1628121
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (239)

Processvia Protein(s)Taxonomy
monoatomic ion transportTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
intracellular calcium ion homeostasisTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cell surface receptor signaling pathwayTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to coldTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to xenobiotic stimulusTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to organic substanceTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to organic cyclic compoundTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
calcium-mediated signalingTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
thermoceptionTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
detection of mechanical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
detection of chemical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
protein homotetramerizationTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cellular response to hydrogen peroxideTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cellular response to organic substanceTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
negative regulation of endothelial cell proliferationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukocyte chemotaxis involved in inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukocyte migration involved in inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukotriene production involved in inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukotriene metabolic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
humoral immune responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of angiogenesisPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukotriene biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
lipoxygenase pathwayPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
positive regulation of bone mineralizationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
dendritic cell migrationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
glucose homeostasisPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
long-chain fatty acid biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of fat cell differentiationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of insulin secretionPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of vascular wound healingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of wound healingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of inflammatory response to woundingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of cytokine production involved in inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of cellular response to oxidative stressPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukotriene A4 biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of reactive oxygen species biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of response to endoplasmic reticulum stressPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of sprouting angiogenesisPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
positive regulation of leukocyte adhesion to arterial endothelial cellPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
lipoxin biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
arachidonic acid metabolic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
lipid oxidationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
protein polymerizationCell division protein FtsZEscherichia coli K-12
cell divisionCell division protein FtsZEscherichia coli K-12
division septum assemblyCell division protein FtsZEscherichia coli K-12
FtsZ-dependent cytokinesisCell division protein FtsZEscherichia coli K-12
protein polymerizationCell division protein FtsZEscherichia coli K-12
cell divisionCell division protein FtsZEscherichia coli K-12
cell septum assemblyCell division protein FtsZEscherichia coli K-12
prostaglandin biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
angiogenesisProstaglandin G/H synthase 2Homo sapiens (human)
response to oxidative stressProstaglandin G/H synthase 2Homo sapiens (human)
embryo implantationProstaglandin G/H synthase 2Homo sapiens (human)
learningProstaglandin G/H synthase 2Homo sapiens (human)
memoryProstaglandin G/H synthase 2Homo sapiens (human)
regulation of blood pressureProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of cell population proliferationProstaglandin G/H synthase 2Homo sapiens (human)
response to xenobiotic stimulusProstaglandin G/H synthase 2Homo sapiens (human)
response to nematodeProstaglandin G/H synthase 2Homo sapiens (human)
response to fructoseProstaglandin G/H synthase 2Homo sapiens (human)
response to manganese ionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of vascular endothelial growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
cyclooxygenase pathwayProstaglandin G/H synthase 2Homo sapiens (human)
bone mineralizationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of prostaglandin biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of fever generationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of synaptic plasticityProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of synaptic transmission, dopaminergicProstaglandin G/H synthase 2Homo sapiens (human)
prostaglandin secretionProstaglandin G/H synthase 2Homo sapiens (human)
response to estradiolProstaglandin G/H synthase 2Homo sapiens (human)
response to lipopolysaccharideProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of peptidyl-serine phosphorylationProstaglandin G/H synthase 2Homo sapiens (human)
response to vitamin DProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to heatProstaglandin G/H synthase 2Homo sapiens (human)
response to tumor necrosis factorProstaglandin G/H synthase 2Homo sapiens (human)
maintenance of blood-brain barrierProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of protein import into nucleusProstaglandin G/H synthase 2Homo sapiens (human)
hair cycleProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of apoptotic processProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of nitric oxide biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of cell cycleProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of vasoconstrictionProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of smooth muscle contractionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of smooth muscle contractionProstaglandin G/H synthase 2Homo sapiens (human)
decidualizationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of smooth muscle cell proliferationProstaglandin G/H synthase 2Homo sapiens (human)
regulation of inflammatory responseProstaglandin G/H synthase 2Homo sapiens (human)
brown fat cell differentiationProstaglandin G/H synthase 2Homo sapiens (human)
response to glucocorticoidProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of calcium ion transportProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of synaptic transmission, glutamatergicProstaglandin G/H synthase 2Homo sapiens (human)
response to fatty acidProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to mechanical stimulusProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to lead ionProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to ATPProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to hypoxiaProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to non-ionic osmotic stressProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to fluid shear stressProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of transforming growth factor beta productionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of cell migration involved in sprouting angiogenesisProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of fibroblast growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of brown fat cell differentiationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of platelet-derived growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
cellular oxidant detoxificationProstaglandin G/H synthase 2Homo sapiens (human)
regulation of neuroinflammatory responseProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stressProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to homocysteineProstaglandin G/H synthase 2Homo sapiens (human)
response to angiotensinProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
xenobiotic metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of glucose metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of steroid metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
intracellular receptor signaling pathwayNuclear receptor ROR-gammaHomo sapiens (human)
circadian regulation of gene expressionNuclear receptor ROR-gammaHomo sapiens (human)
cellular response to sterolNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of circadian rhythmNuclear receptor ROR-gammaHomo sapiens (human)
regulation of fat cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of DNA-templated transcriptionNuclear receptor ROR-gammaHomo sapiens (human)
adipose tissue developmentNuclear receptor ROR-gammaHomo sapiens (human)
T-helper 17 cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (55)

Processvia Protein(s)Taxonomy
calcium channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
intracellularly gated calcium channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
identical protein bindingTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
temperature-gated cation channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
arachidonate 5-lipoxygenase activityPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
arachidonate 12(S)-lipoxygenase activityPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
iron ion bindingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
protein bindingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
hydrolase activityPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
arachidonate 8(S)-lipoxygenase activityPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
GTPase activityCell division protein FtsZEscherichia coli K-12
protein bindingCell division protein FtsZEscherichia coli K-12
GTP bindingCell division protein FtsZEscherichia coli K-12
identical protein bindingCell division protein FtsZEscherichia coli K-12
peroxidase activityProstaglandin G/H synthase 2Homo sapiens (human)
prostaglandin-endoperoxide synthase activityProstaglandin G/H synthase 2Homo sapiens (human)
protein bindingProstaglandin G/H synthase 2Homo sapiens (human)
enzyme bindingProstaglandin G/H synthase 2Homo sapiens (human)
heme bindingProstaglandin G/H synthase 2Homo sapiens (human)
protein homodimerization activityProstaglandin G/H synthase 2Homo sapiens (human)
metal ion bindingProstaglandin G/H synthase 2Homo sapiens (human)
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygenProstaglandin G/H synthase 2Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
protein bindingNuclear receptor ROR-gammaHomo sapiens (human)
oxysterol bindingNuclear receptor ROR-gammaHomo sapiens (human)
zinc ion bindingNuclear receptor ROR-gammaHomo sapiens (human)
ligand-activated transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
sequence-specific double-stranded DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
nuclear receptor activityNuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (37)

Processvia Protein(s)Taxonomy
plasma membraneTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
stereocilium bundleTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
extracellular regionPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
extracellular spacePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear envelopePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear envelope lumenPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nucleoplasmPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
cytosolPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear matrixPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear membranePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
secretory granule lumenPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
perinuclear region of cytoplasmPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
ficolin-1-rich granule lumenPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear envelopePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
cytoplasmCell division protein FtsZEscherichia coli K-12
cell division siteCell division protein FtsZEscherichia coli K-12
plasma membraneCell division protein FtsZEscherichia coli K-12
divisome complexCell division protein FtsZEscherichia coli K-12
cytoplasmCell division protein FtsZEscherichia coli K-12
cell division siteCell division protein FtsZEscherichia coli K-12
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
nuclear inner membraneProstaglandin G/H synthase 2Homo sapiens (human)
nuclear outer membraneProstaglandin G/H synthase 2Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulumProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulum lumenProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulum membraneProstaglandin G/H synthase 2Homo sapiens (human)
caveolaProstaglandin G/H synthase 2Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 2Homo sapiens (human)
protein-containing complexProstaglandin G/H synthase 2Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 2Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 2Homo sapiens (human)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
nucleoplasmNuclear receptor ROR-gammaHomo sapiens (human)
nuclear bodyNuclear receptor ROR-gammaHomo sapiens (human)
chromatinNuclear receptor ROR-gammaHomo sapiens (human)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (135)

Assay IDTitleYearJournalArticle
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID336481Inhibition of COX2 at 10 uM by scintillation proximity assay2002Journal of natural products, Nov, Volume: 65, Issue:11
Screening of ubiquitous plant constituents for COX-2 inhibition with a scintillation proximity based assay.
AID1272754Antibacterial activity against Escherichia coli at 0.25 mol/L after 12 to 24 hrs by paper disc method2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Synthesis, antimicrobial activity of Schiff base compounds of cinnamaldehyde and amino acids.
AID1066639Antagonist at TRPM8 isolated from mouse dorsal root ganglion cells expressed in HEK T-REx cells assessed as inhibition of icilin-induced intracellular Ca2+ influx at >500 uM by fluorescence-based assay2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Activation and inhibition of thermosensitive TRP channels by voacangine, an alkaloid present in Voacanga africana, an African tree.
AID329102Activation of mouse TRPA1 C415S mutant expressed in CHO cells at 100 uM by calcium imaging FLIPR assay2007Nature, Feb-01, Volume: 445, Issue:7127
Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines.
AID1082481Nematicidal activity against second juvenile stage (J2) of Meloidogyne incognita (root-knot nematode) assessed as mortality incubated in the dark at 28 degC after 2 days by light microscopy (benficial crop Tomato)2011Journal of agricultural and food chemistry, Oct-26, Volume: 59, Issue:20
Nematicidal and antifungal activities of annonaceous acetogenins from Annona squamosa against various plant pathogens.
AID1549771Agonist activity at human TRPA1 expressed in HEK293 cells assessed as increase in calcium influx by Fluo-4-AM dye based fluorescence assay2019European journal of medicinal chemistry, May-15, Volume: 170N-Cinnamoylanthranilates as human TRPA1 modulators: Structure-activity relationships and channel binding sites.
AID1755487Half life in human at 0.7 mg/kg, po2020Journal of medicinal chemistry, 12-10, Volume: 63, Issue:23
Curse or Cure? A Perspective on the Developability of Aldehydes as Active Pharmaceutical Ingredients.
AID329099Activation of TRPA12007Nature, Feb-01, Volume: 445, Issue:7127
Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines.
AID1066644Antagonist at TRPM8 isolated from mouse dorsal root ganglion cells expressed in HEK T-REx cells assessed as inhibition of icilin-induced intracellular Ca2+ influx by fluorescence-based assay2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Activation and inhibition of thermosensitive TRP channels by voacangine, an alkaloid present in Voacanga africana, an African tree.
AID1398239Antiproliferative activity against human HCT8 cells after 72 hrs in presence of aspirin by MTT assay2018Bioorganic & medicinal chemistry letters, 09-15, Volume: 28, Issue:17
Novel cinnamaldehyde-based aspirin derivatives for the treatment of colorectal cancer.
AID1549812Agonist activity at human TRPA1 Phe909Ala mutant expressed in HEK293 cells assessed as Ca2+ influx at 30 uM by fluorescence assay2019European journal of medicinal chemistry, May-15, Volume: 170N-Cinnamoylanthranilates as human TRPA1 modulators: Structure-activity relationships and channel binding sites.
AID1581190Agonist activity at mouse TRPA1 expressed in HEK293 cells assessed as increase in calcium influx at 1 uM incubated for 1 min by Fluo-4-AM dye based FLIPR assay2020Journal of medicinal chemistry, 01-09, Volume: 63, Issue:1
Discovery of Nonpungent Transient Receptor Potential Vanilloid 1 (TRPV1) Agonist as Strong Topical Analgesic.
AID1398207Antiproliferative activity against human HCT8 cells after 72 hrs by MTT assay2018Bioorganic & medicinal chemistry letters, 09-15, Volume: 28, Issue:17
Novel cinnamaldehyde-based aspirin derivatives for the treatment of colorectal cancer.
AID482140Activation of TRPA1 channel expressed in CHO cells assessed as increase in intracellular calcium levels2010Journal of medicinal chemistry, Jul-22, Volume: 53, Issue:14
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.
AID299876Antiinflammatory activity against xylene-induced ear edema in Kunming mouse assessed as edema weight at 20 mg/kg, po after 2 hrs relative to control2007Bioorganic & medicinal chemistry, Jul-15, Volume: 15, Issue:14
Toward the development of chemoprevention agents. Part 1: Design, synthesis, and anti-inflammatory activities of a new class of 2,5-disubstituted-dioxacycloalkanes.
AID362785Inhibition of human recombinant PDE5A1 expressed in COS7 cells2008Journal of natural products, Sep, Volume: 71, Issue:9
Potent inhibition of human phosphodiesterase-5 by icariin derivatives.
AID1755485Oral bioavailability in human at 0.7 mg/kg2020Journal of medicinal chemistry, 12-10, Volume: 63, Issue:23
Curse or Cure? A Perspective on the Developability of Aldehydes as Active Pharmaceutical Ingredients.
AID1699025Inhibition of quorum sensing system in Pseudomonas aeruginosa PAO12020Bioorganic & medicinal chemistry, 11-01, Volume: 28, Issue:21
Next generation quorum sensing inhibitors: Accounts on structure activity relationship studies and biological activities.
AID1201466Antimicrobial activity against methicillin-resistant Staphylococcus aureus2015European journal of medicinal chemistry, May-05, Volume: 95Advances in the discovery of novel antimicrobials targeting the assembly of bacterial cell division protein FtsZ.
AID1066645Antagonist at TRPM8 isolated from mouse dorsal root ganglion cells expressed in HEK T-REx cells assessed as inhibition of menthol-induced intracellular Ca2+ influx by fluorescence-based assay2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Activation and inhibition of thermosensitive TRP channels by voacangine, an alkaloid present in Voacanga africana, an African tree.
AID467606Inhibition of mushroom tyrosinase after 10 mins by spectrophotometry2009Journal of natural products, Jun, Volume: 72, Issue:6
Tyrosinase-inhibitory constituents from the twigs of Cinnamomum cassia.
AID1544945Inhibition of NO711 binding to mouse GAT1 expressed in HEK293 cell membranes assessed as residual binding at 1 uM incubated for 4 hrs in presence of NO711 by LC-ESI-MS/MS analysis relative to control2019Bioorganic & medicinal chemistry, 07-01, Volume: 27, Issue:13
Application of the concept of oxime library screening by mass spectrometry (MS) binding assays to pyrrolidine-3-carboxylic acid derivatives as potential inhibitors of γ-aminobutyric acid transporter 1 (GAT1).
AID386014Induction of neurogenic inflammation in rat esophagus assessed as CGRP release per 20 mins at 50 uM2007Proceedings of the National Academy of Sciences of the United States of America, Aug-14, Volume: 104, Issue:33
4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1.
AID385778Induction of neurogenic inflammation in capsaicin desensitized rat dorsal spinal cord assessed as substance P release per 20 mins at 10 uM2007Proceedings of the National Academy of Sciences of the United States of America, Aug-14, Volume: 104, Issue:33
4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1.
AID1628116Antimicrobial activity against Staphylococcus aureus2016Journal of medicinal chemistry, Aug-11, Volume: 59, Issue:15
Targeting the Bacterial Division Protein FtsZ.
AID1326324Antibacterial activity against Bacillus subtilis by broth dilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Recent advances in the discovery and development of antibacterial agents targeting the cell-division protein FtsZ.
AID1755484Bioavailability in human at 10.3 mg2020Journal of medicinal chemistry, 12-10, Volume: 63, Issue:23
Curse or Cure? A Perspective on the Developability of Aldehydes as Active Pharmaceutical Ingredients.
AID385775Induction of neurogenic inflammation in rat dorsal spinal cord assessed as substance P release per 20 mins at 10 uM2007Proceedings of the National Academy of Sciences of the United States of America, Aug-14, Volume: 104, Issue:33
4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1.
AID1326307Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC BAA-41 after 18 hrs by broth microdilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Recent advances in the discovery and development of antibacterial agents targeting the cell-division protein FtsZ.
AID670363Inhibition of xanthine oxidase- mediated uric acid formation at 50 ug/mL after 5 mins by spectrophotometry2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Xanthine oxidase inhibitory activity of constituents of Cinnamomum cassia twigs.
AID1120510Induction of transmembrane potential loss in Bacillus subtilis subsp. subtilis str. 168 at 1 times MIC pre-treated for 5 mins and measured 15 mins post dye addition by DiOC2 dye based flow cytometry2013MedChemComm, Jan-01, Volume: 4, Issue:1
Inhibitors of bacterial tubulin target bacterial membranes
AID1272755Antibacterial activity against Escherichia coli at 0.13 mol/L after 12 to 24 hrs by paper disc method2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Synthesis, antimicrobial activity of Schiff base compounds of cinnamaldehyde and amino acids.
AID1120513Antimicrobial activity against Bacillus subtilis subsp. subtilis str. 168 after 18 hrs by macro-dilution method2013MedChemComm, Jan-01, Volume: 4, Issue:1
Inhibitors of bacterial tubulin target bacterial membranes
AID452237Agonist activity at human TRPA1 expressed in HEK293 cells assessed as [45]Ca2+ influx by microbeta plate count2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Oxime derivatives related to AP18: Agonists and antagonists of the TRPA1 receptor.
AID1272756Antibacterial activity against Escherichia coli at 0.06 mol/L after 12 to 24 hrs by paper disc method2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Synthesis, antimicrobial activity of Schiff base compounds of cinnamaldehyde and amino acids.
AID1603728Inhibition of human PMNL 5-LOX using arachidonic acid as substrate after 5 mins by HPLC method2019Bioorganic & medicinal chemistry, 09-01, Volume: 27, Issue:17
5-Lipoxygenase as a drug target: A review on trends in inhibitors structural design, SAR and mechanism based approach.
AID386016Induction of neurogenic inflammation in capsaicin desensitized rat esophagus assessed as CGRP release per 20 mins at 50 uM2007Proceedings of the National Academy of Sciences of the United States of America, Aug-14, Volume: 104, Issue:33
4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1.
AID670364Inhibition of xanthine oxidase- mediated uric acid formation after 5 mins by spectrophotometry2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Xanthine oxidase inhibitory activity of constituents of Cinnamomum cassia twigs.
AID642414Estrogenic activity at ERalpha in human MVLN cells at 100 ug/mL after 24 hrs by luciferase reporter gene assay relative to E22012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
Discovery of estrogen receptor α modulators from natural compounds in Si-Wu-Tang series decoctions using estrogen-responsive MCF-7 breast cancer cells.
AID377983Cytotoxicity against Salmonella Typhimurium TA100 assessed as maximun non-toxic concentrations after 15 hrs by ELISA1999Journal of natural products, Jan, Volume: 62, Issue:1
Structure-antimutagenic activity relationship study of plicatin B.
AID349484Inhibition of NF-kappaB transfected in LPS-stimulated mouse RAW264.7 cells2008Bioorganic & medicinal chemistry, Oct-15, Volume: 16, Issue:20
Aldehydic components of cinnamon bark extract suppresses RANKL-induced osteoclastogenesis through NFATc1 downregulation.
AID1082480Nematicidal activity against second juvenile stage (J2) of Meloidogyne incognita (root-knot nematode) assessed as mortality incubated in the dark at 28 degC after 3 days by light microscopy (benficial crop Tomato)2011Journal of agricultural and food chemistry, Oct-26, Volume: 59, Issue:20
Nematicidal and antifungal activities of annonaceous acetogenins from Annona squamosa against various plant pathogens.
AID1272752Antifungal activity against Penicillium citrinum at 0.06 mol/L after 2 to 4 days by paper disc method2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Synthesis, antimicrobial activity of Schiff base compounds of cinnamaldehyde and amino acids.
AID329103Activation of mouse TRPA1 C422S mutant expressed in CHO cells at 100 uM by calcium imaging FLIPR assay2007Nature, Feb-01, Volume: 445, Issue:7127
Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines.
AID1628114Inhibition of Escherichia coli FtsZ assessed as reduction in GTPase activity by malachite green assay2016Journal of medicinal chemistry, Aug-11, Volume: 59, Issue:15
Targeting the Bacterial Division Protein FtsZ.
AID1272749Antifungal activity against Aspergillus niger at 0.03 mol/L after 2 to 4 days by paper disc method2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Synthesis, antimicrobial activity of Schiff base compounds of cinnamaldehyde and amino acids.
AID1628120Inhibition of Escherichia coli FtsZ assessed as reduction in polymerization by light scattering method2016Journal of medicinal chemistry, Aug-11, Volume: 59, Issue:15
Targeting the Bacterial Division Protein FtsZ.
AID592088Antihemorrhagic activity in ddY mouse assessed as inhibition of Protobothrops flavoviridis venom-induced hemorrhage incubated with compound for 10 mins measured after 24 hrs2011Bioorganic & medicinal chemistry, Apr-01, Volume: 19, Issue:7
Contribution of cinnamic acid analogues in rosmarinic acid to inhibition of snake venom induced hemorrhage.
AID385770Induction of neurogenic inflammation in rat esophagus assessed as substance P release per 20 mins at 50 uM in calcium free medium2007Proceedings of the National Academy of Sciences of the United States of America, Aug-14, Volume: 104, Issue:33
4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1.
AID1201465Antimicrobial activity against Escherichia coli relative to control2015European journal of medicinal chemistry, May-05, Volume: 95Advances in the discovery of novel antimicrobials targeting the assembly of bacterial cell division protein FtsZ.
AID1201463Inhibition of Escherichia coli FtsZ polymerization2015European journal of medicinal chemistry, May-05, Volume: 95Advances in the discovery of novel antimicrobials targeting the assembly of bacterial cell division protein FtsZ.
AID1100922Insecticidal activity against Mechoris ursulus assessed as mortality at 2.5 mg/paper at 25 +/- 1 degC measured after 48 hr by filter paper diffusion method2000Journal of agricultural and food chemistry, Jun, Volume: 48, Issue:6
Insecticidal and fumigant activities of Cinnamomum cassia bark-derived materials against Mechoris ursulus (Coleoptera: attelabidae).
AID1326317Antimicrobial activity against vancomycin-resistant Enterococcus faecalis after 18 hrs by broth microdilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Recent advances in the discovery and development of antibacterial agents targeting the cell-division protein FtsZ.
AID642415Estrogenic activity at ERalpha in human MVLN cells at 20 ug/mL after 24 hrs by luciferase reporter gene assay relative to E22012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
Discovery of estrogen receptor α modulators from natural compounds in Si-Wu-Tang series decoctions using estrogen-responsive MCF-7 breast cancer cells.
AID1201467Antimicrobial activity against Bacillus subtilis2015European journal of medicinal chemistry, May-05, Volume: 95Advances in the discovery of novel antimicrobials targeting the assembly of bacterial cell division protein FtsZ.
AID385779Induction of neurogenic inflammation in rat dorsal spinal cord assessed as CGRP release per 20 mins at 10 uM in calcium free medium2007Proceedings of the National Academy of Sciences of the United States of America, Aug-14, Volume: 104, Issue:33
4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1.
AID403340Inhibition of COX22005Journal of natural products, Jul, Volume: 68, Issue:7
Expanding the ChemGPS chemical space with natural products.
AID1326319Antibacterial activity against Klebsiella pneumoniae ATCC BAA-1144 after 18 hrs by broth microdilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Recent advances in the discovery and development of antibacterial agents targeting the cell-division protein FtsZ.
AID1272748Antifungal activity against Aspergillus niger at 0.06 mol/L after 2 to 4 days by paper disc method2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Synthesis, antimicrobial activity of Schiff base compounds of cinnamaldehyde and amino acids.
AID1191756Inhibition of human purified MPG pre-incubated with compound for 10 mins followed by addition of 1,N6 ethenoadenine containing 32P-labeled duplex oligonucleotide substrates at 20 uM by gel-based excision activity assay2015Bioorganic & medicinal chemistry, Mar-01, Volume: 23, Issue:5
Naturally occurring polyphenol, morin hydrate, inhibits enzymatic activity of N-methylpurine DNA glycosylase, a DNA repair enzyme with various roles in human disease.
AID1272758Antibacterial activity against Staphylococcus aureus at 0.25 mol/L after 12 to 24 hrs by paper disc method2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Synthesis, antimicrobial activity of Schiff base compounds of cinnamaldehyde and amino acids.
AID1082482Nematicidal activity against second juvenile stage (J2) of Meloidogyne incognita (root-knot nematode) assessed as mortality incubated in the dark at 28 degC after 1 day by light microscopy (benficial crop Tomato)2011Journal of agricultural and food chemistry, Oct-26, Volume: 59, Issue:20
Nematicidal and antifungal activities of annonaceous acetogenins from Annona squamosa against various plant pathogens.
AID385773Induction of neurogenic inflammation in rat dorsal spinal cord assessed as substance P release per 20 mins at 10 uM in calcium free medium2007Proceedings of the National Academy of Sciences of the United States of America, Aug-14, Volume: 104, Issue:33
4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1.
AID1755486Drug excretion in human urine at 0.7 mg/kg, po measured after 8 to 24 hrs2020Journal of medicinal chemistry, 12-10, Volume: 63, Issue:23
Curse or Cure? A Perspective on the Developability of Aldehydes as Active Pharmaceutical Ingredients.
AID1167300Antioxidant activity assessed as DPPH radical scavenging activity incubated at room temperature for 20 mins by UV-visible spectrophotometry2014Bioorganic & medicinal chemistry letters, Nov-01, Volume: 24, Issue:21
Design, synthesis and exploring the quantitative structure-activity relationship of some antioxidant flavonoid analogues.
AID1549805Agonist activity at human TRPA1 Cys261Ala mutant expressed in HEK293 cells assessed as Ca2+ influx at 30 uM by fluorescence assay2019European journal of medicinal chemistry, May-15, Volume: 170N-Cinnamoylanthranilates as human TRPA1 modulators: Structure-activity relationships and channel binding sites.
AID1120509Increase in bacterial membrane permeability in Bacillus subtilis subsp. subtilis str. 168 at 1 times MIC pre-treated for 5 mins and measured 30 mins post dye addition by propidium iodide dye based flow cytometry2013MedChemComm, Jan-01, Volume: 4, Issue:1
Inhibitors of bacterial tubulin target bacterial membranes
AID1272759Antibacterial activity against Staphylococcus aureus at 0.13 mol/L after 12 to 24 hrs by paper disc method2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Synthesis, antimicrobial activity of Schiff base compounds of cinnamaldehyde and amino acids.
AID1272760Antibacterial activity against Staphylococcus aureus at 0.06 mol/L after 12 to 24 hrs by paper disc method2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Synthesis, antimicrobial activity of Schiff base compounds of cinnamaldehyde and amino acids.
AID1326306Antibacterial activity against Escherichia coli ATCC 25922 after 18 hrs by broth microdilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Recent advances in the discovery and development of antibacterial agents targeting the cell-division protein FtsZ.
AID1184716Negative allosteric modulation of recombinant HA-tagged GB1 subunit/Flag-tagged GB2 subunit receptor (unknown origin) expressed in HEK293 cells co-expressing Gqi9 G-protein assessed as inhibition of GABA-induced IP production at 100 uM by liquid scintilla2014ACS medicinal chemistry letters, Jul-10, Volume: 5, Issue:7
Discovery of a Negative Allosteric Modulator of GABAB Receptors.
AID329104Activation of mouse TRPA1 C622S mutant expressed in CHO cells at 100 uM by calcium imaging FLIPR assay2007Nature, Feb-01, Volume: 445, Issue:7127
Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines.
AID1100921Insecticidal activity against Mechoris ursulus assessed as mortality at 1 mg/paper at 25 +/- 1 degC measured after 48 hr by filter paper diffusion method2000Journal of agricultural and food chemistry, Jun, Volume: 48, Issue:6
Insecticidal and fumigant activities of Cinnamomum cassia bark-derived materials against Mechoris ursulus (Coleoptera: attelabidae).
AID1469806Cysteamine reactivity of the compound in TRIS-HCL assessed as second order rate constant at 40 uM and pH 7.42017Journal of medicinal chemistry, 02-09, Volume: 60, Issue:3
Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions.
AID1120502Protonophore activity in Bacillus subtilis subsp. subtilis str. 168 assessed as induction of rapid equlibration of delta-pH at 1 times MIC2013MedChemComm, Jan-01, Volume: 4, Issue:1
Inhibitors of bacterial tubulin target bacterial membranes
AID349480Inhibition of bone resorption by mature osteoclast in RANKL-stimulated mouse RAW264.7 cells pretreated for 1 hr measured after 8 days2008Bioorganic & medicinal chemistry, Oct-15, Volume: 16, Issue:20
Aldehydic components of cinnamon bark extract suppresses RANKL-induced osteoclastogenesis through NFATc1 downregulation.
AID385774Induction of neurogenic inflammation in rat dorsal spinal cord assessed as CGRP peptide release per 20 mins at 10 uM2007Proceedings of the National Academy of Sciences of the United States of America, Aug-14, Volume: 104, Issue:33
4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1.
AID349478Inhibition of NFATc1 expression in RANKL-stimulated mouse RAW264.7 cells after 48 hrs by immunoblotting2008Bioorganic & medicinal chemistry, Oct-15, Volume: 16, Issue:20
Aldehydic components of cinnamon bark extract suppresses RANKL-induced osteoclastogenesis through NFATc1 downregulation.
AID1439502Antiparasitic activity against L3 and L4 larval stages of Ascaris suum2017European journal of medicinal chemistry, Mar-31, Volume: 129Medicinal plants used as anthelmintics: Ethnomedical, pharmacological, and phytochemical studies.
AID385772Induction of neurogenic inflammation in capsaicin desensitized rat dorsal spinal cord assessed as CGRP peptide release per 20 mins at 10 uM2007Proceedings of the National Academy of Sciences of the United States of America, Aug-14, Volume: 104, Issue:33
4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1.
AID1201468Antimicrobial activity against Escherichia coli2015European journal of medicinal chemistry, May-05, Volume: 95Advances in the discovery of novel antimicrobials targeting the assembly of bacterial cell division protein FtsZ.
AID1204253Antibacterial activity against Bacillus subtilis2015European journal of medicinal chemistry, Jun-05, Volume: 97Design, synthesis and antibacterial activity of cinnamaldehyde derivatives as inhibitors of the bacterial cell division protein FtsZ.
AID1100923Insecticidal activity against Mechoris ursulus assessed as mortality at 5 mg/paper at 25 +/- 1 degC measured after 48 hr by filter paper diffusion method2000Journal of agricultural and food chemistry, Jun, Volume: 48, Issue:6
Insecticidal and fumigant activities of Cinnamomum cassia bark-derived materials against Mechoris ursulus (Coleoptera: attelabidae).
AID377982Antimutagenic activity in Salmonella Typhimurium TA100 assessed as inhibition of ethyl methanesulfonate-induced mutation at 25 ug/mL treated for 30 mins and measured after 2 days by modified Ames test1999Journal of natural products, Jan, Volume: 62, Issue:1
Structure-antimutagenic activity relationship study of plicatin B.
AID174708Gastric cytoprotective activity in male wistar rat1997Journal of medicinal chemistry, Jun-06, Volume: 40, Issue:12
Structure-cytoprotective activity relationship of simple molecules containing an alpha,beta-unsaturated carbonyl system.
AID1272750Antifungal activity against Penicillium citrinum at 0.25 mol/L after 2 to 4 days by paper disc method2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Synthesis, antimicrobial activity of Schiff base compounds of cinnamaldehyde and amino acids.
AID386015Induction of neurogenic inflammation in rat esophagus assessed as CGRP release per 20 mins at 50 uM in in calcium free medium2007Proceedings of the National Academy of Sciences of the United States of America, Aug-14, Volume: 104, Issue:33
4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1.
AID386013Induction of neurogenic inflammation in capsaicin desensitized rat esophagus assessed as substance P release per 20 mins at 50 uM2007Proceedings of the National Academy of Sciences of the United States of America, Aug-14, Volume: 104, Issue:33
4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1.
AID1517970Inhibition of human FBPase expressed in Escherichia coli BL21 (DE3) at 500 uM using FBP as substrate incubated for 5 mins by malachite green dye based spectrophotometry relative to control2019European journal of medicinal chemistry, Dec-15, Volume: 184Discovery of novel allosteric site and covalent inhibitors of FBPase with potent hypoglycemic effects.
AID1628115Antimicrobial activity against Bacillus subtilis2016Journal of medicinal chemistry, Aug-11, Volume: 59, Issue:15
Targeting the Bacterial Division Protein FtsZ.
AID1204252Antibacterial activity against Escherichia coli2015European journal of medicinal chemistry, Jun-05, Volume: 97Design, synthesis and antibacterial activity of cinnamaldehyde derivatives as inhibitors of the bacterial cell division protein FtsZ.
AID336478Inhibition of COX2 at 100 uM by scintillation proximity assay2002Journal of natural products, Nov, Volume: 65, Issue:11
Screening of ubiquitous plant constituents for COX-2 inhibition with a scintillation proximity based assay.
AID1326318Antimicrobial activity against vancomycin-sensitive Enterococcus faecalis after 18 hrs by broth microdilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Recent advances in the discovery and development of antibacterial agents targeting the cell-division protein FtsZ.
AID1272757Antibacterial activity against Escherichia coli at 0.03 mol/L after 12 to 24 hrs by paper disc method2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Synthesis, antimicrobial activity of Schiff base compounds of cinnamaldehyde and amino acids.
AID1120500Induction of membrane associated proteins mislocalization in Bacillus subtilis subsp. subtilis str. 168 assessed as reduction in GFP-MinD protein localization by fluorescence assay2013MedChemComm, Jan-01, Volume: 4, Issue:1
Inhibitors of bacterial tubulin target bacterial membranes
AID1628117Antimicrobial activity against Escherichia coli2016Journal of medicinal chemistry, Aug-11, Volume: 59, Issue:15
Targeting the Bacterial Division Protein FtsZ.
AID1326323Antibacterial activity against Escherichia coli by broth dilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Recent advances in the discovery and development of antibacterial agents targeting the cell-division protein FtsZ.
AID1272746Antifungal activity against Aspergillus niger at 0.25 mol/L after 2 to 4 days by paper disc method2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Synthesis, antimicrobial activity of Schiff base compounds of cinnamaldehyde and amino acids.
AID1272761Antibacterial activity against Staphylococcus aureus at 0.03 mol/L after 12 to 24 hrs by paper disc method2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Synthesis, antimicrobial activity of Schiff base compounds of cinnamaldehyde and amino acids.
AID1326320Antibacterial activity against methicillin-sensitive Staphylococcus aureus after 18 hrs by broth microdilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Recent advances in the discovery and development of antibacterial agents targeting the cell-division protein FtsZ.
AID647545Inhibition of beta (1,3) glucan synthase in Candida albicans cell membrane using UDP-Glc as substrate assessed as aniline blue-glucan complex formation by microtiter-based fluorescence method2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
Novel dendrimeric lipopeptides with antifungal activity.
AID1272751Antifungal activity against Penicillium citrinum at 0.13 mol/L after 2 to 4 days by paper disc method2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Synthesis, antimicrobial activity of Schiff base compounds of cinnamaldehyde and amino acids.
AID1201464Antimicrobial activity against Bacillus subtilis relative to control2015European journal of medicinal chemistry, May-05, Volume: 95Advances in the discovery of novel antimicrobials targeting the assembly of bacterial cell division protein FtsZ.
AID762798Inhibition of Wnt/beta-catenin (unknown origin) signaling pathway expressed in HEK293 cells assessed as inhibition of TCF4 transcriptional activity at 5 to 40 uM after 24 hrs by TOPflash reporter gene assay2013Journal of natural products, Jul-26, Volume: 76, Issue:7
Antitumor activity of 2-hydroxycinnamaldehyde for human colon cancer cells through suppression of β-catenin signaling.
AID500219Agonist activity at TRPA12005Nature chemical biology, Jul, Volume: 1, Issue:2
Sensing with TRP channels.
AID1201462Inhibition of Escherichia coli FtsZ GTPase activity2015European journal of medicinal chemistry, May-05, Volume: 95Advances in the discovery of novel antimicrobials targeting the assembly of bacterial cell division protein FtsZ.
AID1581189Agonist activity at human TRPA1 expressed in HEK293 cells assessed as increase in calcium influx at 100 uM incubated for 1 min by Fluo-4-AM dye based FLIPR assay2020Journal of medicinal chemistry, 01-09, Volume: 63, Issue:1
Discovery of Nonpungent Transient Receptor Potential Vanilloid 1 (TRPV1) Agonist as Strong Topical Analgesic.
AID385771Induction of neurogenic inflammation in rat esophagus assessed as substance P release per 20 mins at 50 uM2007Proceedings of the National Academy of Sciences of the United States of America, Aug-14, Volume: 104, Issue:33
4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1.
AID1549782Agonist activity at mouse TRPA1 expressed in CHO cells assessed as increase in calcium influx by Fluo-3 based FLIPR analysis2019European journal of medicinal chemistry, May-15, Volume: 170N-Cinnamoylanthranilates as human TRPA1 modulators: Structure-activity relationships and channel binding sites.
AID349479Inhibition of multinucleated cell formation in RANKL-stimulated mouse RAW264.7 cells at 0.5 to 2 uM after 3 days by TRAP staining2008Bioorganic & medicinal chemistry, Oct-15, Volume: 16, Issue:20
Aldehydic components of cinnamon bark extract suppresses RANKL-induced osteoclastogenesis through NFATc1 downregulation.
AID1326325Antibacterial activity against methicillin-resistant Staphylococcus aureus by broth dilution method2016Bioorganic & medicinal chemistry, 12-15, Volume: 24, Issue:24
Recent advances in the discovery and development of antibacterial agents targeting the cell-division protein FtsZ.
AID1272753Antifungal activity against Penicillium citrinum at 0.03 mol/L after 2 to 4 days by paper disc method2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Synthesis, antimicrobial activity of Schiff base compounds of cinnamaldehyde and amino acids.
AID1272747Antifungal activity against Aspergillus niger at 0.13 mol/L after 2 to 4 days by paper disc method2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Synthesis, antimicrobial activity of Schiff base compounds of cinnamaldehyde and amino acids.
AID1628121Binding affinity to Escherichia coli FtsZ2016Journal of medicinal chemistry, Aug-11, Volume: 59, Issue:15
Targeting the Bacterial Division Protein FtsZ.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1346567Mouse TRPA1 (Transient Receptor Potential channels)2004Neuron, Mar-25, Volume: 41, Issue:6
Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (1,310)

TimeframeStudies, This Drug (%)All Drugs %
pre-199057 (4.35)18.7374
1990's71 (5.42)18.2507
2000's222 (16.95)29.6817
2010's625 (47.71)24.3611
2020's335 (25.57)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 69.25

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index69.25 (24.57)
Research Supply Index7.22 (2.92)
Research Growth Index5.17 (4.65)
Search Engine Demand Index121.41 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (69.25)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials34 (2.54%)5.53%
Reviews46 (3.44%)6.00%
Case Studies27 (2.02%)4.05%
Observational0 (0.00%)0.25%
Other1,230 (92.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (6)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
In-vivo Effects of E-cigarette Aerosol on Innate Lung Host Defense [NCT03700892]19 participants (Actual)Interventional2018-10-19Terminated(stopped due to Covid-19 has been shown to increase risk associated with vaping. To increase participant safety and use real world vaping habits, the investigators plan to continue studying vaping effects on the airways in an observational format.)
Characterization of the Toll-like Receptor 7-agonist Imiquimod 3.75% as a New Surrogate Model of Itch [NCT03943407]0 participants (Actual)Interventional2019-11-30Withdrawn(stopped due to The Imiquimod 3.75% was ineffective)
Temporal Profile of the Nociceptive Desensitization Induced by 8% Topical Capsaicin and the Functional Independence of Transient Receptor Potential Ankyrin 1 (TPRA1)- and Vanilloid 1 (TRPV1)-Expressing Nociceptive Afferents [NCT03132142]22 participants (Anticipated)Interventional2017-04-30Recruiting
The Role of Transient Receptor Potential Channels in Chemotherapy-Induced Peripheral Neuropathic Pain. [NCT04415892]240 participants (Anticipated)Interventional2019-10-01Recruiting
Subacute Effect of Pharmacological Sensory Stimulation of the Oropharynx by Agonists of TRP Receptors in Swallowing Neurophysiology in the Elderly With Oropharyngeal Dysphagia. [NCT04741620]150 participants (Actual)Interventional2019-01-17Completed
The Effect of Capsaicin and Cinnamaldehyde on Intestinal Permeability, Gallbladder Motility and Satiety [NCT01667523]13 participants (Actual)Interventional2011-02-28Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

TrialOutcome
NCT03700892 (4) [back to overview]Absolute Values of Whole Lung MCC for Each Group
NCT03700892 (4) [back to overview]CA-induced Changes in Whole Lung MCC
NCT03700892 (4) [back to overview]Percent Polymorphonuclear Leukocytes (PMN) in Induced Sputum
NCT03700892 (4) [back to overview]CA-induced Changes in Regional Lung MCC

Absolute Values of Whole Lung MCC for Each Group

Baseline Differences in Whole lung MCC clearance rates in Non-smokers/Non-vapers as Compared to E-cigarette Users. Absolute group values of Whole Lung MCC =average % mucus cleared from the whole lung over a 90-minute period. (NCT03700892)
Timeframe: Start of study, up to three months

Interventionpercent clearance (Mean)
E-cigarette Users17
Non-smoker/Non-vaper Healthy Controls14

[back to top]

CA-induced Changes in Whole Lung MCC

Absolute values of whole lung MCC at baseline compared to after CA vaping session. Absolute repeat values of Whole lung MCC = average % mucus cleared from the whole lung over a 90-minute period. (NCT03700892)
Timeframe: Through study completion, an average of three months

Interventionpercent clearance (Mean)
Cinnamaldehyde41
PG/VG27

[back to top]

Percent Polymorphonuclear Leukocytes (PMN) in Induced Sputum

Percent change of PMNs in vapers from baseline compared to post CA vaping session. Percent change in PMNs in vapers from baseline compared to post PG/VG vaping session are included as an additional comparison. (NCT03700892)
Timeframe: Through study completion, an average of three months

Interventionpercent PMN (Mean)
Cinnamaldehyde3.6
PG/VG89.4

[back to top]

CA-induced Changes in Regional Lung MCC

Absolute repeat values of Central and Peripheral lung MCC = average % mucus cleared from the Central and Peripheral lung over a 90-minute period. This will assess clearance rates from the central (C) and peripheral (P) regions as secondary endpoints that may reflect differential effects between a region with relatively more (C) vs. less (P) large bronchial airways. (NCT03700892)
Timeframe: Through study completion, an average of three months

,
Interventionpercent clearance (Mean)
Central LungPeripheral Lung
Cinnamaldehyde4333
PG/VG2524

[back to top]